<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63600</article-id><article-id pub-id-type="doi">10.7554/eLife.63600</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-184665"><name><surname>Hutchins</surname><given-names>Erica J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4316-0333</contrib-id><email>erica.hutchins@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287603"><name><surname>Gandhi</surname><given-names>Shashank</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4081-4338</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287602"><name><surname>Chacon</surname><given-names>Jose</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7965-3976</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127725"><name><surname>Piacentino</surname><given-names>Michael</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1773-031X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1052"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4274-1862</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>Division of Biology and Biological Engineering, California Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Pasadena</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Cell and Tissue Biology, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>The Miller Institute for Basic Research in Science, University of California, Berkeley</institution></institution-wrap><addr-line><named-content content-type="city">Berkeley</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005f5hv41</institution-id><institution>Department of Biology, School of Math and Science, California State University Northridge</institution></institution-wrap><addr-line><named-content content-type="city">Northridge</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Robertson</surname><given-names>Elizabeth</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cheah</surname><given-names>Kathryn Song Eng</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>University of Hong Kong</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e63600</elocation-id><history><date date-type="received" iso-8601-date="2020-09-30"><day>30</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2022-08-22"><day>22</day><month>08</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-10-14"><day>14</day><month>10</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.10.14.338715"/></event></pub-history><permissions><copyright-statement>© 2022, Hutchins et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hutchins et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63600-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-63600-figures-v1.pdf"/><abstract><p>While neural crest development is known to be transcriptionally controlled via sequential activation of gene regulatory networks (GRNs), recent evidence increasingly implicates a role for post-transcriptional regulation in modulating the output of these regulatory circuits. Using available single-cell RNA-sequencing datasets from avian embryos to identify potential post-transcriptional regulators, we found that <italic>Elavl1</italic>, which encodes for an RNA-binding protein with roles in transcript stability, was enriched in the premigratory cranial neural crest. Perturbation of Elavl1 resulted in premature neural crest delamination from the neural tube as well as significant reduction in transcripts associated with the neural crest specification GRN, phenotypes that are also observed with downregulation of the canonical Wnt inhibitor <italic>Draxin</italic>. That <italic>Draxin</italic> is the primary target for stabilization by Elavl1 during cranial neural crest specification was shown by RNA-sequencing, RNA immunoprecipitation, RNA decay measurement, and proximity ligation assays, further supporting the idea that the downregulation of neural crest specifier expression upon Elavl1 knockdown was largely due to loss of <italic>Draxin</italic>. Importantly, exogenous <italic>Draxin</italic> rescued cranial neural crest specification defects observed with Elavl1 knockdown. Thus, Elavl1 plays a critical a role in the maintenance of cranial neural crest specification via <italic>Draxin</italic> mRNA stabilization. Together, these data highlight an important intersection of post-transcriptional regulation with modulation of the neural crest specification GRN.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>As an embryo develops, different genetic programs become activated to give cell populations a specific biological identity that will shape their fate. For instance, when certain sets of genes get switched on, cells from the outermost layer of the embryo start to migrate to their final destination within the body. There, these ‘neural crest cells’ will contribute to bones and cartilage in the face, pigmented skin spots, and muscles or nerves in the gut.</p><p>When genes responsible for the neural crest identity are active, their instructions are copied into an ‘RNA molecule’ which will then relay this information to protein-building structures. How well the RNA can pass on the message depends on how long it persists within the cell. Certain RNA-binding proteins can control this process, but it is unclear whether and how this regulation takes place in neural crest cells. In their work, Hutchins et al. therefore focused on identifying RNA-binding proteins involved in neural crest identity.</p><p>Exploratory searches of genetic data from chick embryos revealed that, even before they started to migrate, neural crest cells which have recently acquired their identity produced large amounts of the RNA-binding protein Elavl1. In addition, these cells did not behave normally when embryos were deprived of the protein: they left the outer layer too soon and then switched off genes important for their identity. Genetic studies of neural crest cells lacking Elavl1 revealed that this effect was due to having lost the RNA molecule produced from the Draxin gene.</p><p>Introducing an additional source of Draxin into mutant embryos missing Elavl1 was enough to restore normal neural crest behaviour. Further biochemical experiments then showed that the RNA for Draxin decayed quickly in the absence of Elavl1. This suggests that the protein normally allows Draxin’s RNA to persist long enough to pass on its message.</p><p>These results reveal a new mechanism controlling the identity and behaviour of the neural crest. Since many cancers in adulthood arise from the descendants of neural crest cells, Hutchins et al. hope that this knowledge could lead to improved therapies in the future.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neural crest</kwd><kwd>Elavl1</kwd><kwd>HuR</kwd><kwd><italic>Draxin</italic></kwd><kwd>specification</kwd><kwd>post-transcriptional regulation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Chicken</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01DE027538</award-id><principal-award-recipient><name><surname>Bronner</surname><given-names>Marianne E</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000042</institution-id><institution>Amgen Foundation</institution></institution-wrap></funding-source><award-id>Caltech Amgen Scholars Program</award-id><principal-award-recipient><name><surname>Chacon</surname><given-names>Jose</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008775</institution-id><institution>California State University, Northridge</institution></institution-wrap></funding-source><award-id>BUILD PODER Program TL4GM118977</award-id><principal-award-recipient><name><surname>Chacon</surname><given-names>Jose</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>K99DE029240</award-id><principal-award-recipient><name><surname>Piacentino</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>K99DE028592</award-id><principal-award-recipient><name><surname>Hutchins</surname><given-names>Erica J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01DE027568</award-id><principal-award-recipient><name><surname>Bronner</surname><given-names>Marianne E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The RNA-binding protein Elavl1 directly binds to and stabilizes a single gene product—<italic>Draxin</italic> mRNA—to prevent premature delamination and maintain specification in cranial neural crest.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Neural crest cells are an essential, multipotent cell population in the vertebrate embryo. During development, these cells undergo coordinated induction, specification, and epithelial–mesenchymal transition (EMT) events to migrate and ultimately form a myriad of tissues, including craniofacial structures, components of the peripheral nervous system, as well as many other derivatives (<xref ref-type="bibr" rid="bib20">Gandhi and Bronner, 2018</xref>). The transcriptional control of these events has been dissected and mapped into modules of a feed-forward gene regulatory network (GRN), which helps explain the detailed sequence of events involved in neural crest development (<xref ref-type="bibr" rid="bib42">Martik and Bronner, 2017</xref>; <xref ref-type="bibr" rid="bib57">Simões-Costa and Bronner, 2015a</xref>; <xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref>). Recently, in addition to transcriptional events, there has been growing appreciation for the role that post-transcriptional regulation plays in the establishment, maintenance, and regulation of neural crest formation (<xref ref-type="bibr" rid="bib5">Bhattacharya et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Cibi et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Copeland and Simoes-Costa, 2020</xref>; <xref ref-type="bibr" rid="bib19">Forman et al., 2021</xref>; <xref ref-type="bibr" rid="bib53">Sánchez-Vásquez et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Ward et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Weiner, 2018</xref>).</p><p>Given that RNA-binding proteins play an essential role in post-transcriptional regulatory processes (<xref ref-type="bibr" rid="bib13">Dassi, 2017</xref>), we sought to broadly identify those with early roles in neural crest development. To this end, we analyzed existing single-cell RNA-sequencing (scRNA-seq) data (<xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref>) from specification-stage avian embryos to identify enriched RNA-binding protein candidates. Using this approach, we identified <italic>Elavl1</italic> as an enriched transcript in newly formed neural crest cells. Elavl1 is a nucleocytoplasmic shuttling protein from the ELAV (embryonic lethal abnormal vision) family of RNA-binding proteins, which have conserved roles in neural development (<xref ref-type="bibr" rid="bib40">Ma et al., 1996</xref>; <xref ref-type="bibr" rid="bib71">Yao et al., 1993</xref>). It is a well-established stabilizer of mRNA, a function often mediated via association with the 3′-untranslated region (3′-UTR) of its mRNA targets (<xref ref-type="bibr" rid="bib1">Abdelmohsen and Gorospe, 2010</xref>; <xref ref-type="bibr" rid="bib52">Rothamel et al., 2021</xref>).</p><p>Elavl1 is essential for mammalian development and embryonic survival; Elavl1 null mouse embryos exhibit lethality due to abnormal placental morphogenesis, and conditional epiblast-null embryos display a broad array of phenotypes, ranging from defects in ossification and craniofacial development to asplenia. Interestingly, despite the myriad of tissue systems affected by Elavl1 knockout and relatively broad expression in wild-type embryos, mechanistic insights suggest Elavl1 acts on specific gene networks in a spatiotemporally controlled manner (<xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>). Thus, due to its complexity and specificity of function, much remains to be discovered with respect to Elavl1’s essential roles and targets during embryonic development across tissue-specific contexts.</p><p>Here, we sought to determine the role of Elavl1 during cranial neural crest specification by taking advantage of the chick embryo model, an amniote system in which it is possible to perturb Elavl1 function with precise spatiotemporal control via unilateral knockdown. The results show that perturbation of Elavl1 led to premature neural crest delamination, as well as significant reduction in the expression of genes within the neural crest specification GRN. We find that these effects were mediated by loss of <italic>Draxin</italic>, a direct mRNA target for stabilization by Elavl1. Our data demonstrate a critical role for Elavl1, and RNA-binding protein-mediated post-transcriptional control, in the regulation of a critical neural crest specification module.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The RNA-binding protein Elavl1/HuR is expressed in cranial neural crest</title><p>Cranial neural crest cells are indispensable for proper craniofacial development (<xref ref-type="bibr" rid="bib64">van Limborgh et al., 1983</xref>; <xref ref-type="bibr" rid="bib65">Vega-Lopez et al., 2018</xref>). Whereas transcription factors have been well-established critical regulators of neural crest development and craniofacial morphogenesis reviewed in <xref ref-type="bibr" rid="bib23">Gou et al., 2015</xref>, growing evidence indicates an essential role for post-transcriptional regulation in these processes (<xref ref-type="bibr" rid="bib10">Cibi et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Copeland and Simoes-Costa, 2020</xref>; <xref ref-type="bibr" rid="bib14">Dennison et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Forman et al., 2021</xref>). To identify RNA-binding proteins with potential roles in cranial neural crest specification, we analyzed scRNA-seq data for cranial neural crest isolated from avian embryos at the 5–6 somite stage (<xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref>) we identified three distinct clusters (neural, premigratory [pNC], and delaminating/migratory [mNC]) among which genes associated with the gene ontology (GO) term ‘binds to 3′-UTR’ were differentially expressed (<xref ref-type="fig" rid="fig1">Figure 1A–E</xref>). To isolate potential positive regulators of neural crest specification, we then performed GO term analysis for ‘stabilizes RNA’ and ‘regulates translation’ among the identified RNA-binding proteins; only the <italic>Elavl1</italic> gene was associated with all three GO terms and abundantly expressed in the isolated cranial neural crest cells (<xref ref-type="fig" rid="fig1">Figure 1F, G</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>RNA-binding proteins are differentially expressed in premigratory and migratory cranial neural crest.</title><p>(<bold>A</bold>) Schematic of early chick cranial neural crest cells at premigratory stages (HH8+/9−) in intact heads and cross-section expressing Citrine fluorescent protein under control of the FoxD3 NC1 enhancer used by Williams et al. to sort cranial neural crest cells for single-cell RNA-sequencing (scRNA-seq; <xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref>). (<bold>B, C</bold>) Dimensionality reduction using Uniform Manifold Approximation and Projection (UMAP) on published scRNA-seq data from <xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref> identified three distinct clusters neural, premigratory (pNC), and delaminating/migratory (mNC). Expression of marker genes (<italic>Sox3</italic> and <italic>Cdh2</italic> for neural, <italic>Pax7</italic> and <italic>Snai2</italic> for premigratory cranial neural crest, and <italic>Sox10</italic> and <italic>Ets1</italic> for early migratory cranial neural crest) was used to label the three subclusters. (<bold>D</bold>) The majority of the FoxD3-NC1<sup>+</sup> cells were also positive for the expression of transcription factors <italic>Pax7</italic> and <italic>Snai2</italic>, which label the dorsal neural tube and premigratory/delaminating neural crest cells. These triple positive NC1<sup>+</sup>/Snai2<sup>+</sup>/Pax7<sup>+</sup> were further processed for gene ontology analysis to identify post-transcriptional regulators. (<bold>E</bold>) A strip-plot showing expression and abundance of a subset of genes that are associated with the gene ontology term ‘binds to 3′-UTR’. (<bold>F</bold>) A three-way Venn diagram shows overlap between genes associated with the gene ontology terms ‘binds RNA’, ‘regulates translation’, and ‘stabilizes RNA’. Only three genes, <italic>Elavl1</italic>, <italic>Dazl</italic>, and <italic>Igf2bp1</italic>, were associated with all three. (<bold>G</bold>) Feature plots showing the expression distribution of the three genes identified in (<bold>F</bold>). Only <italic>Elavl1</italic> is abundant among all NC1<sup>+</sup>/Pax7<sup>+</sup>/Snai2<sup>+</sup> cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig1-v1.tif"/></fig><p>Given that Elavl1 knockout mice often display defects in craniofacial structures (<xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>), and the transcript appeared enriched in premigratory cranial neural crest cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), we hypothesized a potential role for Elavl1 during cranial neural crest specification. To test this possibility, we first examined the expression pattern of Elavl1 in the developing chick embryo. Early in neurulation, when the neural plate border (NPB) is established within the rising neural folds, Elavl1 expression was detected in the anterior open neural tube and closing neural folds surrounding the anterior neuropore but absent from Pax7-expressing NPB cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As the neural tube closed, when neural crest specification is complete, Elavl1 expression became enriched throughout the neural tube and overlapped with Pax7 expression in premigratory cranial neural crest cells (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>). Following cranial neural crest EMT, Elavl1 remained expressed in the migratory neural crest cells, as well as throughout the brain and neural tube (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>). Thus, Elavl1 is expressed in specified, premigratory cranial neural crest cells following establishment of the NPB and is retained during the onset of EMT and in early migrating cranial neural crest cells.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The RNA-binding protein Elavl1 is expressed in premigratory and migratory cranial neural crest.</title><p>Representative epifluorescence images of wild-type HH8− (<bold>A</bold>), HH9 (<bold>B–D</bold>), and HH9+ (<bold>E–G</bold>) chick embryos, in whole mount (<bold>A, B, E</bold>) and cross-section (<bold>C, D; F, G</bold>) immunostained for Elavl1 (cyan) and Pax7 (magenta). Dashed white line (<bold>B, E</bold>) indicates level of cross-section (<bold>C, D; F, G</bold>), respectively; dotted white lines outline regions of premigratory and migratory neural crest as indicated. NF, neural folds; NT, neural tube; pNC, premigratory neural crest; mNC, migratory neural crest. Scale bar, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig2-v1.tif"/></fig></sec><sec id="s2-2"><title>Elavl1 downregulation alters cranial neural crest specification and delamination</title><p>To determine what, if any, role Elavl1 has in cranial neural crest specification, we perturbed Elavl1 function in the early embryo using a translation-blocking antisense morpholino oligo (MO). We electroporated control or Elavl1 MOs bilaterally into gastrula stage chick embryos and analyzed neural crest specification using quantitative fluorescent hybridization chain reaction (HCR) to measure expression of markers of specified neural crest at HH9 (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). Given Elavl1’s association with Wnt signaling (<xref ref-type="bibr" rid="bib37">Kim et al., 2015</xref>) and the essential roles Wnt signaling plays during early neural crest development (<xref ref-type="bibr" rid="bib45">Milet and Monsoro-Burq, 2012</xref>; <xref ref-type="bibr" rid="bib51">Rabadán et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Simões-Costa and Bronner, 2015a</xref>; <xref ref-type="bibr" rid="bib59">Steventon and Mayor, 2012</xref>; <xref ref-type="bibr" rid="bib69">Wu et al., 2003</xref>; <xref ref-type="bibr" rid="bib70">Yanfeng et al., 2003</xref>), we focused on the Wnt effector <italic>Axud1</italic>, its target and neural crest specifier <italic>FoxD3</italic>, and the Wnt antagonist <italic>Draxin</italic> (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>; <xref ref-type="bibr" rid="bib58">Simões-Costa et al., 2015b</xref>). Following Elavl1 knockdown (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; 61.4 ± 0.9% of the control side, p &lt; 0.001, paired <italic>t</italic>-test, <italic>n</italic> = 5 embryos, 15 sections), we observed significant reduction in the levels of <italic>Axud1</italic> (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; 73.7 ± 3.1% of the control side, p = 0.03, Wilcoxon signed-rank test, <italic>n</italic> = 6 embryos), <italic>FoxD3</italic> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>; 61.3 ± 5.5% of the control side, p = 0.002, Wilcoxon signed-rank test, <italic>n</italic> = 10 embryos), and <italic>Draxin</italic> (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; 66.6 ± 1.8% of the control side, p = 0.03, Wilcoxon signed-rank test, <italic>n</italic> = 6 embryos) transcripts compared to contralateral control sides. To parse whether this was a specific effect or a broad defect in neural crest development, we also examined additional neural crest genes and found no significant difference in expression between control or Elavl1 knockdown sides for <italic>Pax7</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; 87.4 ± 3.1% of the control side, p = 0.1, Wilcoxon signed-rank test, <italic>n</italic> = 5 embryos) or <italic>Tfap2b</italic> (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; 98.2 ± 7.0% of the control side, p = 0.6, Wilcoxon signed-rank test, <italic>n</italic> = 4 embryos), indicating a specific defect in a subset of genes required for cranial neural crest specification.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Elavl1 knockdown alters cranial neural crest specification and delamination.</title><p>(<bold>A</bold>) Schematic diagram illustrating experimental design. Gastrula stage chick embryos were electroporated bilaterally with a standard control and translation-blocking morpholino (MO) targeting <italic>Elavl1</italic>. Electroporated embryos were subsequently processed for quantitative hybridization chain reaction (HCR) and analyzed in whole mount, comparing the knockdown to the contralateral control side. (<bold>B</bold>) Quantitation of HCR processed embryos for control versus Elavl1 knockdown for cranial neural crest transcripts, calculated as ratio of Elavl1 MO versus control MO integrated density. Representative confocal maximum intensity projection micrographs for <italic>Axud1</italic> (<italic>n</italic> = 6) (<bold>C</bold>), <italic>FoxD3</italic> (<italic>n</italic> = 10) (<bold>D</bold>), <italic>Draxin</italic> (<italic>n</italic> = 6) (<bold>E</bold>), <italic>Pax7</italic> (<italic>n</italic> = 5) (<bold>F</bold>), and <italic>Tfap2b</italic> (<italic>n</italic> = 4) (<bold>G</bold>) transcripts. Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm. *p &lt; 0.05, Wilcoxon signed-rank test. (<bold>H</bold>) Representative apotome maximum intensity projection micrographs of cross-sectioned embryo bilaterally co-electroporated with a fluorescent electroporation control construct (H2B-RFP) and control MO (left) or Elavl1 MO (right) immunostained for Pax7 (yellow). Nuclei were stained with DAPI (4′,6-diamidino-2-phenylindole)(blue). Dotted white line indicates midline. Dashed white lines indicate limit of dorsal neural tube. Arrows indicate ‘neural tube’ Pax7 cells. Asterisks indicate ‘delaminated’ Pax7 cells. Scale bar, 20 μm. (<bold>I</bold>) Quantification of the ratio of Pax7 + cells on Elavl1 MO (right) versus control MO (left) sides of cross-sections. Data are from individual sections; sections from same embryo are displayed in same color (<italic>n</italic> = 4 embryos, 11 sections). *p ≤ 0.002, one-sample Wilcoxon signed-rank test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Translation-blocking morpholino suppresses Elavl1 expression.</title><p>(<bold>A</bold>) Representative apotome maximum intensity projection micrograph of cross-sectioned embryo bilaterally co-electroporated with a fluorescent electroporation control construct (H2B-RFP) and control morpholino (left) or Elavl1 morpholino (right), immunostained for Elavl1 (cyan). Dotted white line indicates midline. MO, morpholino. Scale bar, 20 μm. (<bold>B</bold>) Relative fluorescence intensity of Elavl1 for Elavl1 knockdown compared to control sides of cross-sections, calculated as ratio of Elavl1 morpholino versus control morpholino integrated density. Data are from individual sections; sections from same embryo are displayed in same color (<italic>n</italic> = 5 embryos, 15 sections). *p &lt; 0.001, paired <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Elavl1 knockdown inhibits cranial neural crest emigration.</title><p>(<bold>A</bold>) Representative confocal maximum intensity projection micrograph of whole mount embryo bilaterally co-electroporated with a fluorescent electroporation control construct (H2B-RFP) and control morpholino (left) or Elavl1 morpholino (right), immunostained for Pax7 (yellow). Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm. (<bold>B</bold>) Relative migration distance for electroporated sides compared to control sides of whole mount embryos, calculated as ratio. Data are from individual embryos (<italic>n</italic> = 5 embryos, 5 measurements per embryo averaged). <italic>*</italic>p &lt; 0.001, Wilcoxon matched-pairs signed-rank test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig3-figsupp2-v1.tif"/></fig></fig-group><p>We also performed immunostaining for Pax7 in cross-section to assess if Elavl1 knockdown altered neural crest cell number or dorsal neural tube morphology. Interestingly, the total number of Pax7 + cells was unaffected with Elavl1 knockdown (101.3 ± 4.5% of the control side, p = 0.6, one-sample Wilcoxon signed-rank test, <italic>n</italic> = 4 embryos, 11 sections); however, we found a significant increase in the number of Pax7 + cells that delaminated from the neural tube (139.4 ± 8.4% of the control side, p = 0.002, one-sample Wilcoxon signed-rank test), and concomitant decrease in the number of Pax7 + cells retained within the dorsal neural tube (66.0 ± 5.3% of the control side, p = 0.001, one-sample Wilcoxon signed-rank test: <xref ref-type="fig" rid="fig3">Figure 3H, I</xref>). To determine what impact premature delamination might have on cranial neural crest migration, we also performed whole mount immunostaining for Pax7 at HH9 + and found significant decrease in cranial neural crest emigration away from the midline (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>; 63.6 ± 4.1% of the control side, p &lt; 0.001, Wilcoxon matched-pairs signed-rank test, <italic>n</italic> = 5 embryos, 5 measurements per embryo averaged). Taken together, these data suggest that Elavl1 is required during early cranial neural crest development to regulate specification and prevent premature delamination.</p></sec><sec id="s2-3"><title><italic>Draxin</italic> is the primary target of Elavl1 during cranial neural crest specification</title><p>To parse the mechanism of Elavl1 function during cranial neural crest specification, we sought to more broadly identify the RNA targets of Elavl1 using bulk RNA-sequencing (RNA-seq) and differential gene expression analysis (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Given that Elavl1 is known to bind to and stabilize its RNA targets via 3′-UTR interaction (<xref ref-type="bibr" rid="bib9">Chen et al., 2002</xref>; <xref ref-type="bibr" rid="bib16">Dormoy-Raclet et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>; <xref ref-type="bibr" rid="bib52">Rothamel et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Shi et al., 2020</xref>), we expected expression of potential targets to be reduced with Elavl1 knockdown. Among the differentially expressed genes we identified (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), 12 were significantly downregulated, with four having established roles in neural crest development and which we validated using HCR—<italic>Axud1</italic>, <italic>Draxin</italic>, <italic>BMP4</italic>, and <italic>Msx1</italic> (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). We also identified several canonical neural crest genes that were unaffected with Elavl1 knockdown (e.g<italic>.</italic>, <italic>Pax7</italic>, <italic>Tfap2b</italic>, <italic>Snai2</italic>, <italic>Sox9</italic>, and <italic>Zeb2</italic>), consistent with HCR data (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Together these data suggest Elavl1 does not broadly bind and stabilize the transcripts of neural crest genes, rather it targets specific RNAs to drive cranial neural crest specification.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Draxin</italic> mRNA is the primary target of Elavl1 during cranial neural crest specification.</title><p>(<bold>A</bold>) Schematic diagram illustrating experimental design for RNA-sequencing (RNA-seq). Gastrula stage chick embryos were electroporated bilaterally with a standard control and translation-blocking morpholino (MO) targeting <italic>Elavl1</italic>. Dorsal neural folds were dissected from stage HH8+/9− embryos, pooled (<italic>n</italic> = 3), and processed for bulk RNA-seq (three biological replicates). (<bold>B</bold>) Volcano plot following differential expression analysis and filtering of RNA-seq data. Of the 24 genes differentially expressed following Elavl1 knockdown (12 upregulated, 12 downregulated), four genes (<italic>Draxin</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, <italic>BMP4</italic>) have established roles in neural crest development and were significantly downregulated. (<bold>C</bold>) Schematic diagram illustrating experimental design for RNA stability assay. Gastrula stage chick embryos were electroporated bilaterally with control or translation-blocking morpholino (MO) targeting <italic>Elavl1</italic>. Dorsal neural folds were dissected from stage HH8+/9− embryos; left neural folds were used as the 0 hr time point, whereas right neural folds were treated with actinomycin D for 30 min, 2 hr, or 4 hr prior to total RNA extraction and quantitative reverse transcription-PCR (qRT-PCR) to measure RNA decay. (<bold>D</bold>) Transcript stability plots show <italic>Draxin</italic> mRNA stability is significantly reduced (*p = 0.001, Mann–Whitney test) with Elavl1 knockdown (blue) compared to control (gray), whereas other neural crest mRNAs (<italic>Axud1</italic>, <italic>Msx1</italic>, <italic>BMP4</italic>, <italic>Pax7</italic>) are not (<italic>ns</italic>, nonsignificant, p &gt; 0.37, Mann–Whitney test). (<bold>E</bold>) Schematic illustrating experimental design of RNA-binding protein/RNA co-immunoprecipitation (RIP) to test RNA association with Elavl1 in vivo for neural crest targets. Lysates generated from HH9 heads were incubated with antibody-coated beads for Elavl1 or a nonspecific IgG to co-immunoprecipitate protein with bound RNAs. In qRT-PCR, specifically bound RNAs would be more abundant and reach threshold before RNAs that were nonspecific, and therefore would have smaller <italic>C</italic><sub>T</sub> values. <italic>C</italic><sub>T</sub>, threshold cycle. (<bold>F</bold>) Fold enrichment of RNAs eluted from RIP (<italic>n</italic> = 16 embryos), quantified by qRT-PCR, performed in triplicate. <italic>ns</italic>, nonsignificant, p = 0.89, one-way analysis of variance (ANOVA) with Tukey’s post hoc test. *p &lt; 0.001, one-way ANOVA with Tukey’s post hoc test. Error bars, standard error of the mean (SEM). (<bold>G</bold>) Schematic diagram illustrating experimental design for proximity ligation assay (PLA). Gastrula stage chick embryos were electroporated bilaterally with a construct expressing a nuclear localized, GFP-tagged MS2 bacteriophage coat protein (MCP-GFP) alone (left) or in combination with a construct containing a Luciferase coding region, MS2 stem loops (which are bound by MCP when transcribed), and the endogenous <italic>Draxin</italic> 3′-untranslated region (MS2-<italic>Draxin</italic> 3′UTR) (right). Following fixation and cross-sectioning at HH9, tissues were incubated with primary antibodies made in goat and rabbit that recognized GFP and Elavl1, respectively. Secondary antibodies against goat and rabbit IgG were labeled with complementary oligonucleotides that generate a fluorescent signal due to rolling circle amplification only when in close proximity (&lt;40 nm). Thus, fluorescence signal (magenta) would indicate in vivo interaction between MCP-GFP and endogenous Elavl1. (<bold>H</bold>) Representative confocal maximum intensity projection micrograph of dorsal neural folds from cross-sectioned HH9 embryo bilaterally electroporated with MCP-GFP (green) alone (‘control’, left) or with MS2-<italic>Draxin</italic> 3′-UTR (‘experimental’, right), processed for PLA (magenta) as illustrated in panel (<bold>G</bold>), and stained for DAPI (blue). Boxes in (<bold>H</bold>) indicate zoomed-in areas in (<bold>H’’</bold>) and (<bold>H’’’</bold>). Scale bar, 5 μm. (<bold>I</bold>) Quantitation of total number of PLA puncta per section for (<italic>n</italic> = 3 embryos, 2 sections/embryo). *p = 0.016, two-tailed Wilcoxon matched-pairs signed-rank test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>RNA-sequencing (RNA-seq) identified four neural crest genes specifically downregulated with Elavl1 knockdown.</title><p>Although RNA-seq identified four genes with established roles in neural crest development (<italic>Draxin</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, <italic>BMP4</italic>) that were significantly downregulated with Elavl1 knockdown (<bold>A</bold>), several other neural crest genes were unaffected (<bold>B</bold>). (<bold>B</bold>) Volcano plot of genes that were not significantly different for Elavl1 knockdown versus control, with known neural crest genes <italic>Pax7</italic>, <italic>Tfab2b</italic>, <italic>Snai2</italic>, <italic>Sox9</italic>, and <italic>Zeb2</italic> indicated. Representative confocal maximum intensity projection micrographs of hybridization chain reaction (HCR) processed embryos for <italic>Msx1</italic> (<italic>n</italic> = 6) (<bold>C</bold>), <italic>BMP4</italic> (<italic>n</italic> = 6) (<bold>D</bold>), and <italic>Snai2</italic> (<italic>n</italic> = 8) (<bold>E</bold>). (<bold>F</bold>) Quantitation of HCR processed embryos for control versus Elavl1 knockdown, calculated as ratio of Elavl1 MO versus control MO integrated density. Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm. *p &lt; 0.001; <italic>ns</italic>, nonsignificant, p = 0.54; one sample <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Putative Elavl1-binding sites within the <italic>Draxin</italic> 3′-untranslated region (UTR) predicts a direct interaction.</title><p>Representative secondary structures of the <italic>Draxin</italic> UTR (<bold>A</bold>), <italic>Axud1</italic> 3′-UTR (<bold>B</bold>), <italic>Msx1</italic> 3′-UTR (<bold>C</bold>), <italic>BMP4</italic> 3′-UTR (<bold>D</bold>), <italic>Pax7</italic> 3′-UTR (<bold>E</bold>), and <italic>Tfap2b</italic> 3′-UTR (<bold>F</bold>), predicted by ‘mfold’ analysis. Predicted Elavl1-binding sites are highlighted using magenta dots.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Notably, <italic>FoxD3</italic> failed to meet our stringency cutoff during RNA-seq analysis due to low expression at the examined stages, and is likely downregulated with Elavl1 knockdown (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) due to indirect effects from loss of <italic>Axud1</italic> (<xref ref-type="bibr" rid="bib58">Simões-Costa et al., 2015b</xref>) and therefore unlikely to be a <italic>bona fide</italic> target of Elavl1. To determine whether Elavl1 directly or indirectly interacts with <italic>Axud1</italic>, <italic>Draxin</italic>, <italic>BMP4</italic>, and <italic>Msx1</italic> mRNAs, we first measured the rate of mRNA decay with actinomycin D treatment to assess the stability of these RNAs, and <italic>Pax7</italic> as a nontarget, with or without Elavl1 knockdown (<xref ref-type="fig" rid="fig4">Figure 4C</xref>); if Elavl1 is required for transcript stability, target RNAs should decay at a faster rate with loss of Elavl1 compared to control. Interestingly, among all the transcripts tested, only <italic>Draxin</italic> had a significant reduction in transcript stability (p = 0.001, Mann–Whitney test; <xref ref-type="fig" rid="fig4">Figure 4D</xref>), suggesting that <italic>Draxin</italic> is the primary target bound and stabilized by Elavl1 during cranial neural crest specification.</p><p>To test this hypothesis, we searched the 3′-UTR sequences of <italic>Draxin</italic>, <italic>Axud1</italic>, <italic>BMP4</italic>, <italic>Msx1</italic>, <italic>Pax7</italic>, and <italic>Tfap2b</italic> mRNAs for putative Elavl1-binding sites. The <italic>Draxin</italic> 3′-UTR contained four high probability-binding sites, whereas the other 3′-UTRs contained only one (<italic>BMP4</italic>, <italic>Msx1</italic>) or none (<italic>Axud1</italic>, <italic>Pax7</italic>, <italic>Tfap2b;</italic> <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Given that Elavl1 contains three RNA recognition motifs (RRMs) that cooperate for RNA recognition (<xref ref-type="bibr" rid="bib49">Pabis et al., 2019</xref>), it is possible that multiple contacts are required for Elavl1 to bind and stabilize RNAs in vivo, and by extension is unlikely for Elavl1 to bind RNAs with only a single putative binding site. Thus, we hypothesize that Elavl1 specifically targets and stabilizes <italic>Draxin</italic> in cranial neural crest through multiple contact sites within its 3′-UTR.</p><p>To confirm that <italic>Draxin</italic> mRNA is bound by Elavl1 in vivo, we first performed an RNA immunoprecipitation (RIP) followed by quantitative reverse transcription-PCR (qRT-PCR) to pull down endogenous Elavl1 ribonucleoprotein (RNP) complexes. To this end, we incubated lysate generated from wild-type HH9 embryonic heads with magnetic beads coated with either Elavl1 antibody or a rabbit IgG nonspecific control antibody, then eluted bound RNA and performed qRT-PCR, comparing immunoprecipitated RNAs (‘IP’) with RNAs extracted from a fraction of the input lysate (‘Input’). We expected that RNAs bound by Elavl1 would be enriched in the IP compared to the Input, whereas nonspecifically associated RNAs, that is nontargets, would not (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). We found that <italic>Pax7</italic> and <italic>FoxD3</italic> mRNAs (nontargets) were neither enriched in the IP, nor significantly different from each other (p = 0.89, one-way analysis of variance (ANOVA) with Tukey’s post hoc test); however, <italic>Draxin</italic> mRNA was significantly enriched with Elavl1 IP compared to <italic>Pax7</italic> and <italic>FoxD3</italic> (p &lt; 0.001, one-way ANOVA with Tukey’s post hoc test; <xref ref-type="fig" rid="fig4">Figure 4F</xref>), suggesting that Elavl1 specifically associated with endogenous <italic>Draxin</italic> mRNA. However, this assay could not distinguish whether <italic>Draxin</italic> was bound directly or indirectly, or where within the transcript it might be associating with Elavl1.</p><p>To test whether <italic>Draxin</italic> was directly bound by Elavl1 within the 3′-UTR, we performed a proximity ligation assay (PLA), wherein in situ fluorescent signal can be detected as puncta only when two proteins are in close proximity (&lt;40 nm), indicating a direct interaction in vivo. Taking advantage of the MS2-MCP reporter system (<xref ref-type="bibr" rid="bib63">Tutucci et al., 2018</xref>), we electroporated a construct encoding a GFP-tagged MS2 bacteriophage coat protein (MCP-GFP) alone (‘Control’) or in combination with (‘Experimental’) a construct containing a Luciferase coding region, MS2 stem loops (bound by MCP when transcribed), and the endogenous <italic>Draxin</italic> 3′-untranslated region (MS2-<italic>Draxin</italic> 3′-UTR) and performed PLA with antibodies against Elavl1 and GFP (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). We observed significantly more PLA puncta with expression of MS2-<italic>Draxin</italic> 3′-UTR (<xref ref-type="fig" rid="fig4">Figure 4H–I</xref>), indicating a specific and direct interaction between Elavl1 and the <italic>Draxin</italic> 3′-UTR.</p></sec><sec id="s2-4"><title>Elavl1 maintains cranial neural crest specification via <italic>Draxin</italic> mRNA stabilization</title><p>Our data suggest that Elavl1 specifically binds and stabilizes <italic>Draxin</italic> mRNA as its primary target during cranial neural crest specification. To determine if defects in cranial neural crest specification with Elavl1 knockdown were indirect, and due to <italic>Draxin</italic> downregulation, we examined <italic>FoxD3</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, and <italic>BMP4</italic> expression in Draxin knockdown embryos. We electroporated control and Draxin MO (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>) bilaterally, and performed HCR at HH9. As with Elavl1 MO (<xref ref-type="fig" rid="fig3">Figure 3</xref>), we observed significant reduction in the levels of <italic>FoxD3</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; 26.8 ± 3.2% of the control side, p &lt; 0.02, Wilcoxon matched-pairs signed rank, <italic>n</italic> = 7 embryos), <italic>Axud1</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; 48.8 ± 5.1% of the control side, p &lt; 0.01, paired <italic>t</italic>-test, <italic>n</italic> = 7 embryos), <italic>Msx1</italic> (<xref ref-type="fig" rid="fig5">Figure 5C</xref>; 49.7 ± 5.8% of the control side, p &lt; 0.01, paired <italic>t</italic>-test, <italic>n</italic> = 4 embryos), and <italic>BMP4</italic> (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; 63.6 ± 4.0% of the control side, p &lt; 0.01, paired <italic>t</italic>-test, <italic>n</italic> = 4 embryos) transcripts compared to contralateral control sides (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Elavl1 knockdown phenotypes are rescued by <italic>Draxin</italic>.</title><p>Representative confocal maximum intensity projection micrographs of hybridization chain reaction (HCR) processed embryos for <italic>FoxD3</italic> (<italic>n</italic> = 7) (<bold>A</bold>), <italic>Axud1</italic> (<italic>n</italic> = 7) (<bold>B</bold>), <italic>Msx1</italic> (<italic>n</italic> = 4) (<bold>C</bold>), and <italic>BMP4</italic> (<italic>n</italic> = 4) (<bold>D</bold>) transcripts in whole mount embryos bilaterally electroporated with control morpholino (left) or Draxin morpholino (right). Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm. (<bold>E</bold>) Quantitation of HCR processed embryos for control versus Elavl1 knockdown, calculated as ratio of Elavl1 MO versus control MO integrated density. *p &lt; 0.02, Wilcoxon matched-pairs signed rank or paired <italic>t</italic>-test as indicated in text. Representative confocal maximum intensity projection micrographs of HCR processed embryos for <italic>FoxD3</italic> (<italic>n</italic> = 6) (<bold>F</bold>), <italic>Axud1</italic> (<italic>n</italic> = 6) (<bold>G</bold>), <italic>Msx1</italic> (<italic>n</italic> = 5) (<bold>H</bold>), and <italic>BMP4</italic> (<italic>n</italic> = 5) (<bold>I</bold>) transcripts in whole mount embryos bilaterally electroporated with control morpholino (left) or Elavl1 morpholino and a Draxin overexpression construct (right). Dotted white line indicates midline. MO, morpholino. Scale bar, 50 μm. (<bold>J</bold>) Quantitation of HCR processed embryos for control versus Elavl1 knockdown with Draxin rescue, calculated as ratio of Elavl1 MO + Draxin versus control MO integrated density. <italic>ns</italic>, nonsignificant, p &gt; 0.09, Wilcoxon signed-rank test. Grayed values indicating Elavl1 MO data were originally presented in <xref ref-type="fig" rid="fig3">Figure 3</xref> and are reproduced here to illustrate rescue. *p &lt; 0.05, one-tailed paired <italic>t</italic>-test. (<bold>K</bold>) Representative apotome maximum intensity projection micrographs of cross-sectioned embryo bilaterally electroporated with control MO (left) or Elavl1 MO + Draxin overexpression (right), immunostained for Pax7 (yellow). Draxin overexpression is indicated by expression of H2B-RFP (magenta). Nuclei were stained with DAPI (blue). Dotted white line indicates midline. Dashed white lines indicate limit of dorsal neural tube. Arrows indicate ‘neural tube’ Pax7 cells. Asterisks indicate ‘delaminated’ Pax7 cells. Scale bar, 20 μm. (<bold>L</bold>) Quantification of the ratio of Pax7 + cells on Elavl1 MO + Draxin (right, ‘Rescue’) versus control MO (left) sides of cross-sections. Data are from individual sections; sections from same embryo are displayed in same color (<italic>n</italic> = 3 embryos, 6 sections). <italic>ns</italic>, nonsignificant, p &gt; 0.12, one-sample Wilcoxon signed-rank test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-63600-fig5-v1.tif"/></fig><p>We next asked whether <italic>Draxin</italic> upregulation alone was sufficient to rescue the Elavl1 MO phenotype (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>). To this end, we co-electroporated Elavl1 MO with a Draxin overexpression construct (Draxin-FLAG; <xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>), and assessed neural crest specification with HCR. Indeed, exogenous <italic>Draxin</italic> was sufficient to significantly restore <italic>FoxD3</italic> (<xref ref-type="fig" rid="fig5">Figure 5F</xref>; 84.5 ± 9.6% of the control side, <italic>n</italic> = 6 embryos), <italic>Axud1</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>; 90.3 ± 5.0% of the control side, <italic>n</italic> = 6 embryos), <italic>Msx1</italic> (<xref ref-type="fig" rid="fig5">Figure 5H</xref>; 91.0 ± 1.5% of the control side, <italic>n</italic> = 5 embryos), and <italic>BMP4</italic> (<xref ref-type="fig" rid="fig5">Figure 5I</xref>; 96.5 ± 3.1% of the control side, <italic>n</italic> = 5 embryos) expression from Elavl1 knockdown (p &lt; 0.05, one-tailed paired <italic>t</italic>-test) to expression levels not significantly different from control (<xref ref-type="fig" rid="fig5">Figure 5J</xref>; p &gt; 0.09, Wilcoxon signed-rank test). To determine if exogenous <italic>Draxin</italic> was sufficient to rescue the premature delamination phenotype (<xref ref-type="fig" rid="fig3">Figure 3H, I</xref>) caused by Elavl1 knockdown, we also performed immunostaining for Pax7 in cross-section to assess neural crest cell number and dorsal neural tube morphology. Indeed, co-electroporation of Draxin-FLAG with Elavl1 MO was able to rescue the number of Pax7 + cells that delaminated and remained within the dorsal neural tube to near-control levels (<xref ref-type="fig" rid="fig5">Figure 5L</xref>; 91.6 ± 4.0% and 105.8 ± 12.0% of the control side, respectively, <italic>n</italic> = 3 embryos, 6 sections, p &gt; 0.12, one-sample Wilcoxon signed-rank test). Taken together, these data indicate that <italic>Draxin</italic> mRNA is the primary target of Elavl1 in premigratory cranial neural crest and is stabilized via 3′-UTR interaction to maintain neural crest specification.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Understanding of neural crest development has been greatly enhanced by the identification of key transcriptional circuits that control its developmental progression. Recent studies suggest a critical role for post-transcriptional regulation in the refinement of the expression outputs of these GRNs. Here, we identified and characterized Elavl1 as an RNA-binding protein essential for the maintenance of cranial neural crest specification via its stabilization of the Wnt antagonist <italic>Draxin</italic>. We found that loss of Elavl1, and by extension its target, <italic>Draxin</italic>, interferes with output from multiple nodes of the GRNs required for neural crest specification, including those driven by Wnt and BMP (<xref ref-type="bibr" rid="bib26">Hovland et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Simões-Costa et al., 2015b</xref>; <xref ref-type="bibr" rid="bib62">Tribulo et al., 2003</xref>). Together, our data implicate Elavl1 as a point of integration to coordinate signaling from parallel but independent GRNs.</p><p>At a mechanistic level, our study is consistent with previous work examining Elavl1 function in other cellular contexts, with respect to its role as a stabilizing RNA-binding protein via 3′-UTR interaction (<xref ref-type="bibr" rid="bib9">Chen et al., 2002</xref>; <xref ref-type="bibr" rid="bib16">Dormoy-Raclet et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>; <xref ref-type="bibr" rid="bib52">Rothamel et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Shi et al., 2020</xref>). In the context of embryonic development, our study aligns well with data from knockout mouse consistent with an important role for Elavl1 in intersecting signaling cascades; interestingly, this prior work similarly observed indirect downregulation of <italic>BMP4</italic> with loss of Elavl1, though an upstream mediator remained unidentified (<xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>). In neural crest specification, we identified a single biologically relevant target of Elavl1, whereas prior high-throughput studies found many RNAs directly bound by Elavl1 (<xref ref-type="bibr" rid="bib48">Mukherjee et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Rothamel et al., 2021</xref>). Whether this is a feature specific to neural crest is unclear, though the knockout mouse work suggests that during embryonic development Elavl1 function and RNA targets are driven by spatiotemporal determinants (<xref ref-type="bibr" rid="bib34">Katsanou et al., 2009</xref>), which may be due RNP complex heterogeneity as a result of tissue-specific expression of other interacting RNA-binding proteins. Taken in the context of these prior studies, we speculate that despite broad tissue expression of Elavl1 across embryonic development, specificity in neural crest is achieved through spatiotemporally regulated combinatorial expression of post-transcriptional regulators and RNA regulons (<xref ref-type="bibr" rid="bib36">Keene, 2007</xref>; <xref ref-type="bibr" rid="bib35">Keene and Tenenbaum, 2002</xref>).</p><p>It is important to note that, while Elavl1 expression persists in cranial neural crest during the initiation of EMT and migration, <italic>Draxin</italic> must be rapidly downregulated for these processes to proceed (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>; <xref ref-type="bibr" rid="bib31">Hutchins et al., 2021</xref>). Thus, we hypothesize that Elavl1 becomes endogenously displaced from <italic>Draxin</italic> at the onset of EMT, though it is yet unclear how this is achieved. RNA-binding proteins are known to alter association with targets due to post-translational modifications such as phosphorylation or alternative RNA-binding protein competition (<xref ref-type="bibr" rid="bib13">Dassi, 2017</xref>; <xref ref-type="bibr" rid="bib22">García-Mauriño et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2015</xref>). Indeed, inhibition of serine–threonine kinases has been shown in neural crest to increase cell–cell adhesions and negatively impact cell migration (<xref ref-type="bibr" rid="bib46">Monier-Gavelle and Duband, 1995</xref>), suggesting kinase-driven signaling pathway activation coincident with neural crest EMT; this is interesting given established roles for serine–threonine phosphorylation in modulating Elavl1-RNA-binding activity and target selection (<xref ref-type="bibr" rid="bib24">Grammatikakis et al., 2017</xref>). Thus, we speculate that Elavl1 serine–threonine phosphorylation, either in combination with or as an alternative to competitive RNA-binding protein displacement, likely facilitates <italic>Draxin</italic> release and turnover at the onset of EMT.</p><p>Because its primary target during specification is downregulated while Elavl1 expression persists, this suggests there are likely additional targets and roles for Elavl1 beyond <italic>Draxin</italic> stabilization. Elavl1 has been shown in other contexts to stabilize Snail1 (<xref ref-type="bibr" rid="bib15">Dong et al., 2007</xref>) and matrix metalloprotease-9 (MMP-9) (<xref ref-type="bibr" rid="bib72">Yuan et al., 2011</xref>), factors with well-established roles in neural crest EMT (<xref ref-type="bibr" rid="bib7">Cano et al., 2000</xref>; <xref ref-type="bibr" rid="bib33">Kalev-Altman et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Monsonego-Ornan et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Strobl-Mazzulla and Bronner, 2012</xref>; <xref ref-type="bibr" rid="bib61">Taneyhill et al., 2007</xref>). Given that the neural crest specification GRNs is proceeded by activation of an EMT GRN also coinciding with Elavl1 expression, we speculate that Elavl1 likely intersects with additional GRNs following specification. It is possible one or more of the downregulated genes we identified through RNA-seq that were not important for specification may yet be targets of Elavl1, with functions later in neural crest development. To fully understand how Elavl1 exerts control over key developmental processes, these possibilities will need to be explored.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Model organism and embryo collection</title><p>Fertile chicken eggs (<italic>Gallus gallus</italic>) were purchased locally (Sun State Ranch, Monrovia, CA), and incubated in a humidified 37°C incubator to the specified Hamburger–Hamilton (HH) stage (<xref ref-type="bibr" rid="bib25">Hamburger and Hamilton, 1951</xref>). Live embryos were removed from eggs with Whatman filter paper as described (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>) and stored in Ringer’s solution until further processing.</p></sec><sec id="s4-2"><title>Immunohistochemistry and HCR</title><p>For whole mount immunohistochemistry, embryos were fixed at room temperature for 20 min with 4% paraformaldehyde in sodium phosphate buffer. For cross-sections, embryos were fixed at room temperature for 1 hr, then washed, embedded, and cryosectioned as described (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>) prior to immunohistochemistry. Washes, blocking (10% donkey serum), and antibody incubations were performed in TBSTx (0.5 M Tris–HCl/1.5 M NaCl/10 mM CaCl<sub>2</sub>/0.5% Triton X-100/0.001% Thimerosal) as described (<xref ref-type="bibr" rid="bib8">Chacon and Rogers, 2019</xref>; <xref ref-type="bibr" rid="bib41">Manohar et al., 2020</xref>). Primary antibodies are listed in the Key Resources Table. Species-specific secondary antibodies were labeled with Alexa Fluor 568 and 647 (Invitrogen) and used at 1:1000 or 1:500, respectively. For nuclear staining on cross-sections, DAPI (4′,6-diamidino-2-phenylindole) was added to the secondary antibody solution at [14.3 μM] final concentration. Coverslips were mounted using Fluoromount-G (SouthernBiotech).</p><p>HCR was performed as described (<xref ref-type="bibr" rid="bib21">Gandhi et al., 2020</xref>). Embryos were fixed at room temperature for 1 hr with 4% paraformaldehyde in phosphate-buffered saline (PBS) prior to HCR processing. Custom HCR probes were designed and ordered through Molecular Technologies.</p></sec><sec id="s4-3"><title>Gene expression constructs and perturbation</title><p>Translation-blocking antisense MO for Elavl1 (Gene Tools; Key Resources Table) was designed to span the <italic>Elavl1</italic> (GenBank: NM_204833.1) start codon from nucleotide −20 to +5, and electroporated at [2 mM]. Draxin MO was described previously (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>), and electroporated at [1 mM]. The standard control MO (Gene Tools) was used for contralateral control electroporation. MOs were co-electroporated with pCIG (<xref ref-type="bibr" rid="bib44">Megason and McMahon, 2002</xref>) or pCI-H2B-RFP (<xref ref-type="bibr" rid="bib4">Betancur et al., 2010</xref>) to increase electroporation efficiency and to visualize successfully electroporated cells. The <italic>Draxin</italic>-FLAG overexpression construct (<italic>Draxin</italic> OE; <xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>) and the MCP-GFP construct <xref ref-type="bibr" rid="bib30">Hutchins et al., 2020</xref> have been previously described. The MS2-<italic>Draxin</italic> 3′-UTR construct used in this study was generated by exchanging the mTurq2 coding region for a Luciferase coding region in a previously described MS2-<italic>Draxin</italic> 3′-UTR construct (<xref ref-type="bibr" rid="bib30">Hutchins et al., 2020</xref>). Electroporations were performed on HH4 gastrula stage chicken embryos as described previously (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>).</p></sec><sec id="s4-4"><title>RNA-seq and data analysis</title><p>For single-cell RNA-seq analysis, raw data from <xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref> were downloaded from Gene Expression Omnibus (GEO; GSE130500) and processed for quality assessment using FastQC (<xref ref-type="bibr" rid="bib3">Andrews, 2014</xref>). The reads were trimmed and filtered using Cutadapt (<xref ref-type="bibr" rid="bib43">Martin, 2011</xref>), following which they were aligned to the chicken galgal6 (GRCg6a) genome assembly using Bowtie2 (<xref ref-type="bibr" rid="bib38">Langmead and Salzberg, 2012</xref>). The alignment files generated were used to count features using HTSeq-Count (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>). All further analyses were performed in R using Seurat (<xref ref-type="bibr" rid="bib6">Butler et al., 2018</xref>) as previously described (<xref ref-type="bibr" rid="bib21">Gandhi et al., 2020</xref>). GO terms associated with all genes in the chicken genome were identified using the biomaRt package (<xref ref-type="bibr" rid="bib17">Durinck et al., 2009</xref>). This dataset was queried for the ontology terms expected to be associated with RNA-binding proteins, such as ‘binds mRNA’, ‘binds 3′-UTR’, ‘regulates translation’, and ‘stabilizes RNA’. All feature plots and strip plots were made using Seurat.</p><p>For bulk RNA-seq, dorsal neural folds from morpholino-electroporated embryos grown to stage HH8+/9− were dissected in DEPC-treated PBS and pooled (<italic>n</italic> = 3) before total RNA was extracted using an RNAqueous-Micro kit (Thermo). cDNA libraries (three biological replicates per treatment) were prepared from 10 ng total RNA per pooled sample using the Takara Bio SMART-Seq v4 Ultra Low Input cDNA kit, according to the manufacturer’s instructions. Single-end RNA-sequencing was performed at the Caltech Millard and Muriel Jacobs Genetics and Genomics Laboratory at a depth of 20 million reads. Reads were processed and differential expression analysis was performed as described (<xref ref-type="bibr" rid="bib31">Hutchins et al., 2021</xref>; <xref ref-type="bibr" rid="bib50">Piacentino et al., 2021</xref>). We subsequently filtered the gene lists to exclude lowly expressed genes (average normalized count values &lt;250), resulting in a filtered list of 24 differentially expressed genes (12 downregulated, 12 upregulated) with greater than 1.5-fold change and p &lt; 0.05 cutoff.</p></sec><sec id="s4-5"><title>RNA decay assay</title><p>Embryos were electroporated bilaterally with either control MO or Elavl1 MO and grown to HH8+/9−. Dorsal neural folds were dissected in DEPC-treated PBS, pooled (<italic>n</italic> = 3), and suspended in explant culture media (Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum, 10% chick embryo extract, and 1% penicillin/streptomycin). Actinomycin D [10 μg/ml] or DMSO (dimethyl sulfoxide) alone (for 0 hr time point) was added to neural fold samples, which were then incubated at 37°C/5% CO<sub>2</sub> for 0 hr, 30 min, 2 hr, or 4 hr. Following the specified incubation time, neural fold samples were centrifuged at 300 × <italic>g</italic> for 3 min to remove media then washed three times with DEPC-treated PBS.</p><p>Total RNA was then extracted using the RNAqueous-Micro kit (Thermo) and 50 ng of RNA was reverse transcribed using SuperScript III and oligo dT priming. Following reverse transcription, we performed qPCR using FastStart Universal SYBR Green Master (Rox) with cDNA (diluted 1:10) and gene-specific primers (Key Resources Table) on a QuantStudio 3 Real-Time PCR System (Applied Biosystems) in triplicate. Average <italic>C</italic><sub>T</sub> values were calculated for 0 hr time points. Individual <italic>C</italic><sub>T</sub> values for 30 min, 2 hr, and 4 hr actinomycin D time points were subtracted from the 0 hr average <italic>C</italic><sub>T</sub>, and fold change was calculated for each technical replicate from the start of transcription inhibition (<italic>t</italic> = 0 hr) to each actinomycin D time point for each target. RNA decay rates were calculated and plotted using one phase decay in Prism9 (<italic>n</italic> = three biological replicates).</p></sec><sec id="s4-6"><title>RIP and qRT-PCR</title><p>RIP was performed as described (<xref ref-type="bibr" rid="bib27">Hutchins and Szaro, 2013</xref>; <xref ref-type="bibr" rid="bib32">Jayaseelan et al., 2014</xref>), with minor modifications. Briefly, Protein-G Dynabeads were washed with NT-2 (50 mM Tris–HCl, 150 mM NaCl, 1 mM MgCl<sub>2</sub>, 0.05% NP-40), blocked in NT-2/5% bovine serum albumin (BSA) for 1 hr at room temperature, then incubated with 5 μg antibody (Elavl1 IgG or Control IgG) in NT-2/5% BSA for 1 hr at room temperature. Following antibody incubation, antibody-coated beads were washed with NT-2 and resuspended in NET-2 (NT-2, 20 mM EDTA (ethylenediaminetetraacetic acid), 400 U RNaseOUT, 1× cOmplete, Mini EDTA-free Protease Inhibitor) until addition of cleared lysate.</p><p>Embryonic heads were dissected in Ringer’s solution, washed in RNase-free PBS, and dissociated in Accumax (Innovative Cell Technologies) for 15 min at room temperature. Following dissociation, cells were pelleted at 2000 × <italic>g</italic> for 4 min at 4°C, washed in RNase-free PBS, and resuspended in polysome lysis buffer (0.1 M KCl, 5 mM MgCl<sub>2</sub>, 10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 0.5% NP-40, 200 U RNaseOUT, 1× cOmplete, Mini EDTA-free Protease Inhibitor). Cells were frozen at −80 °C overnight to complete lysis and reduce adventitious binding. Lysate was then thawed on ice, vortexed, and centrifuged at 14,000 × <italic>g</italic> for 10 min at 4°C to remove cellular debris, then cleared lysate was added to antibody-coated beads in NET-2. Immediately following addition of cleared lysate, 10% was removed to serve as an Input control. IP reaction was tumbled at room temperature for 1 hr, beads were then washed in NT-2, and RNA was eluted in proteinase K buffer (NT-2, 1% sodium dodecyl sulfate, 1.2 mg/ml proteinase K) for 30 min at 55°C and phenol/chloroform extracted.</p><p>RNA from Input and IP samples was reverse transcribed using SuperScript III and oligo dT priming. Following reverse transcription, we performed qPCR using FastStart Universal SYBR Green Master (Rox) with cDNA (diluted 1:5) and gene-specific primers (Key Resources Table) on a QuantStudio 3 Real-Time PCR System (Applied Biosystems) in triplicate. We determined Δ<italic>C</italic><sub>T</sub> (Δ<italic>C</italic><sub>T</sub> = Input <italic>C</italic><sub>T</sub> − IP C<sub>T</sub>) for <italic>Draxin</italic>, <italic>FoxD3</italic>, and <italic>Pax7</italic> for Elavl1 and Control IgG RIP samples, then calculated fold enrichment values (=2<sup>(Average Control IgG ΔC<sub>T</sub>− Elavl1 ΔC<sub>T</sub></sup><sup>)</sup>) for each target and replicate.</p></sec><sec id="s4-7"><title>Proximity ligation assay</title><p>Embryos were electroporated bilaterally with MCP-GFP alone (‘control’), or MCP-GFP and MS2-<italic>Draxin</italic> 3′-UTR (‘experimental’), grown to stage HH9, then fixed at room temperature for 1 hr, washed, embedded, and cryosectioned as described (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; <xref ref-type="bibr" rid="bib29">Hutchins and Bronner, 2019</xref>). Sections were processed using a DuoLink PLA kit (Millipore/Sigma) with Anti-Rabbit MINUS PLA probe, anti-Goat PLUS PLA probe, and Far Red PLA detection reagent, and primary antibodies for Elavl1 and GFP, according to the manufacturer’s DuoLink PLA Fluorescence protocol.</p></sec><sec id="s4-8"><title>Image acquisition and analysis</title><p>Confocal images were acquired using an upright Zeiss LSM 880 at the Caltech Biological Imaging Facility, and epifluorescence images were acquired using a Zeiss Imager.M2 with an ApoTome.2 module. Images were minimally processed for brightness/contrast and pseudocolored using Fiji (ImageJ, NIH) and Adobe Photoshop.</p><p>Relative fluorescence intensity was determined in Fiji. For each whole mount image, the line tool was used to draw an ROI surrounding the area of neural crest indicated by positive HCR fluorescence for the genes examined. For cross-sections, ROIs were drawn surrounding the neural crest and neural tube based on tissue morphology from nuclear staining. Following background subtraction (50-pixel rolling ball radius), integrated density was quantified for the ROIs on the control electroporated (left) and experimental electroporated (right) sides from the same embryo. Relative fluorescence intensity was then calculated by dividing the integrated density measurements for the experimental versus the control side of the same embryo.</p><p>Pax7 cell counts were performed as described (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>). The limit of the dorsal neural tube and characterization of cells as ‘delaminated’ or ‘neural tube’ was determined based on tissue morphology from nuclear staining. For relative migration distance determined from Pax7-stained embryos, distance of migration was measured in Fiji as described (<xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>).</p><p>For PLA analysis, confocal micrographs were processed in Fiji. Following background subtraction (50-pixel rolling ball radius), ROIs were drawn surrounding the neural crest and neural tube based on tissue morphology from nuclear staining, then puncta (PLA signal) were counted using ‘analyze particles’ function following global manual thresholding to reduce the appearance of nonspecific puncta outside of electroporated regions.</p></sec><sec id="s4-9"><title>Cloning of the <italic>Gallus Axud1</italic> 3′-UTR</title><p>Given that the 3′-UTR sequence of <italic>Gallus Axud1</italic> was not available in a public repository, to determine whether the <italic>Axud1</italic> 3′-UTR contained potential Elavl1-binding sites, we performed 3′-Rapid Amplification of cDNA Ends (3′-RACE) as described (<xref ref-type="bibr" rid="bib55">Scotto-Lavino et al., 2006</xref>). Briefly, reverse transcription was performed using the <italic>Q</italic><sub>T</sub> primer on total RNA extracted from HH8-9 embryos. First round PCR was performed on <italic>Q</italic><sub>T</sub>-primed cDNA using the <italic>Q</italic><sub>O</sub> primer and <italic>Axud1</italic> Gene-Specific Primer 1. Second round PCR was then performed on this amplification product using the <italic>Q</italic><sub>I</sub> primer and <italic>Axud1</italic> Gene-Specific Primer 2. The resulting PCR product was cloned into the pGEM-T Easy vector (Promega) and eight of these clones were sequenced, and the consensus 3′-UTR sequence deposited to GenBank (Accession # ON920861). Primer sequences can be found in the Key Resources Table.</p></sec><sec id="s4-10"><title>RNA structure and Elavl1-binding site prediction</title><p>Secondary structures for the <italic>Draxin</italic> 3′-UTR (GenBank: AB427147.1), <italic>Axud1</italic> 3′-UTR (GenBank: ON920861), <italic>Msx1</italic> 3′-UTR (Ensembl: ENSGALT00000024209.4), <italic>BMP4</italic> 3′-UTR (Ensembl: ENSGALT00000020316.7), <italic>Pax7</italic> 3′-UTR (Ensembl: ENSGALT00000048594.2), and <italic>Tfap2b</italic> 3′-UTR (Ensembl: ENSGALT00000026916.6) were predicted using ‘mfold’ web server with default settings (<xref ref-type="bibr" rid="bib73">Zuker, 2003</xref>). Elavl1-binding sites were predicted using RBPDB (<xref ref-type="bibr" rid="bib11">Cook et al., 2011</xref>) with 0.9 threshold.</p></sec><sec id="s4-11"><title>Statistical analyses</title><p>Statistical analyses were performed using Prism (8, 9; GraphPad Software). p values are defined in the text, and significance was established with p &lt; 0.05. p values were calculated using Wilcoxon signed-rank, Mann–Whitney, one-sample <italic>t</italic>-tests, one-way ANOVA with post hoc Tukey, unpaired or paired <italic>t</italic>-tests as indicated; tests were two-tailed unless otherwise specified in the text/legend. Data were confirmed to be normally distributed using Kolmogorov–Smirnov or Kruskal–Wallis tests for parametric tests. Data measuring fluorescence intensities or cell counts for Experimental/Control sides are presented as box plots with individual data points shown. Bar graphs representing qPCR fold enrichment are presented as mean values, with error bars indicating standard error of the mean. The number of embryos and replicates is indicated in figure legends and/or text. Post hoc power analyses (<xref ref-type="bibr" rid="bib18">Faul et al., 2007</xref>) confirmed sufficient statistical power was reached (≥0.8) for reported p values and sample sizes.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-63600-transrepform1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>RNA-sequencing datasets have been deposited on NCBI under the accession number PRJNA861325. The 3' untranslated region (UTR) sequence for Axud1 has been deposited to GenBank under accession number ON920861.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Chacon</surname><given-names>J</given-names></name><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><source>NCBI GenBank</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/ON920861">ON920861</pub-id><year iso-8601-date="2022">2022</year><data-title>RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification</data-title></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Chacon</surname><given-names>J</given-names></name><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA861325">PRJNA861325</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RM</given-names></name><name><surname>Candido-Ferreira</surname><given-names>I</given-names></name><name><surname>Repapi</surname><given-names>E</given-names></name><name><surname>Gavriouchkina</surname><given-names>D</given-names></name><name><surname>Senanayake</surname><given-names>U</given-names></name><name><surname>Telenius</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>I</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Sauka-Spengler</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Reconstruction of the global neural crest gene regulatory network in vivo</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121527">GSE121527</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank A Collazo and G Spigolon for imaging assistance at the Caltech Biological Imaging Facility; M Schwarzkopf and G Shin (Molecular Technologies) for HCR probe design; I Antoshechkin of the Caltech Millard and Muriel Jacobs Genetics and Genomics Laboratory for sequencing of RNA-seq libraries; S Manohar for assistance with <italic>Axud1</italic> 3′-RACE; and G da Silva Pescador and R Galton for assistance with pilot experiments.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelmohsen</surname><given-names>K</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Posttranscriptional regulation of cancer traits by hur</article-title><source>Wiley Interdisciplinary Reviews. RNA</source><volume>1</volume><fpage>214</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1002/wrna.4</pub-id><pub-id pub-id-type="pmid">21935886</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>FastQC A quality control tool for high throughput sequence data</data-title><version designator="GPL v3">GPL v3</version><source>Babraham</source><ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname><given-names>P</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name><name><surname>Sauka-Spengler</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genomic code for sox10 activation reveals a key regulatory enhancer for cranial neural crest</article-title><source>PNAS</source><volume>107</volume><fpage>3570</fpage><lpage>3575</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906596107</pub-id><pub-id pub-id-type="pmid">20139305</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>D</given-names></name><name><surname>Rothstein</surname><given-names>M</given-names></name><name><surname>Azambuja</surname><given-names>AP</given-names></name><name><surname>Simoes-Costa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Control of neural crest multipotency by wnt signaling and the lin28/<italic>let-7</italic> axis</article-title><source>eLife</source><volume>7</volume><elocation-id>e40556</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.40556</pub-id><pub-id pub-id-type="pmid">30520734</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cano</surname><given-names>A</given-names></name><name><surname>Pérez-Moreno</surname><given-names>MA</given-names></name><name><surname>Rodrigo</surname><given-names>I</given-names></name><name><surname>Locascio</surname><given-names>A</given-names></name><name><surname>Blanco</surname><given-names>MJ</given-names></name><name><surname>del Barrio</surname><given-names>MG</given-names></name><name><surname>Portillo</surname><given-names>F</given-names></name><name><surname>Nieto</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression</article-title><source>Nature Cell Biology</source><volume>2</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/35000025</pub-id><pub-id pub-id-type="pmid">10655586</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacon</surname><given-names>J</given-names></name><name><surname>Rogers</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Early expression of tubulin beta-III in avian cranial neural crest cells</article-title><source>Gene Expression Patterns</source><volume>34</volume><elocation-id>119067</elocation-id><pub-id pub-id-type="doi">10.1016/j.gep.2019.119067</pub-id><pub-id pub-id-type="pmid">31369820</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CYA</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Shyu</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Highly selective actions of hur in antagonizing AU-rich element-mediated mrna destabilization</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>7268</fpage><lpage>7278</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.20.7268-7278.2002</pub-id><pub-id pub-id-type="pmid">12242302</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cibi</surname><given-names>DM</given-names></name><name><surname>Mia</surname><given-names>MM</given-names></name><name><surname>Guna Shekeran</surname><given-names>S</given-names></name><name><surname>Yun</surname><given-names>LS</given-names></name><name><surname>Sandireddy</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Hota</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neural crest-specific deletion of <italic>rbfox2</italic> in mice leads to craniofacial abnormalities including cleft palate</article-title><source>eLife</source><volume>8</volume><elocation-id>e45418</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45418</pub-id><pub-id pub-id-type="pmid">31241461</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>KB</given-names></name><name><surname>Kazan</surname><given-names>H</given-names></name><name><surname>Zuberi</surname><given-names>K</given-names></name><name><surname>Morris</surname><given-names>Q</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>RBPDB: a database of RNA-binding specificities</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D301</fpage><lpage>D308</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1069</pub-id><pub-id pub-id-type="pmid">21036867</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeland</surname><given-names>J</given-names></name><name><surname>Simoes-Costa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Post-transcriptional tuning of FGF signaling mediates neural crest induction</article-title><source>PNAS</source><volume>117</volume><fpage>33305</fpage><lpage>33316</lpage><pub-id pub-id-type="doi">10.1073/pnas.2009997117</pub-id><pub-id pub-id-type="pmid">33376218</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dassi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Handshakes and fights: the regulatory interplay of RNA-binding proteins</article-title><source>Frontiers in Molecular Biosciences</source><volume>4</volume><elocation-id>67</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2017.00067</pub-id><pub-id pub-id-type="pmid">29034245</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennison</surname><given-names>BJC</given-names></name><name><surname>Larson</surname><given-names>ED</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Mo</surname><given-names>J</given-names></name><name><surname>Fantauzzo</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Srsf3 mediates alternative RNA splicing downstream of pdgfrα signaling in the facial mesenchyme</article-title><source>Development</source><volume>148</volume><elocation-id>dev199448</elocation-id><pub-id pub-id-type="doi">10.1242/dev.199448</pub-id><pub-id pub-id-type="pmid">34184034</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>XL</given-names></name><name><surname>Chu</surname><given-names>YK</given-names></name><name><surname>Ma</surname><given-names>QJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Stabilization of snail by hur in the process of hydrogen peroxide induced cell migration</article-title><source>Biochemical and Biophysical Research Communications</source><volume>356</volume><fpage>318</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.02.145</pub-id><pub-id pub-id-type="pmid">17350594</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dormoy-Raclet</surname><given-names>V</given-names></name><name><surname>Ménard</surname><given-names>I</given-names></name><name><surname>Clair</surname><given-names>E</given-names></name><name><surname>Kurban</surname><given-names>G</given-names></name><name><surname>Mazroui</surname><given-names>R</given-names></name><name><surname>Di Marco</surname><given-names>S</given-names></name><name><surname>von Roretz</surname><given-names>C</given-names></name><name><surname>Pause</surname><given-names>A</given-names></name><name><surname>Gallouzi</surname><given-names>I-E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The RNA-binding protein hur promotes cell migration and cell invasion by stabilizing the beta-actin mrna in a U-rich-element-dependent manner</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>5365</fpage><lpage>5380</lpage><pub-id pub-id-type="doi">10.1128/MCB.00113-07</pub-id><pub-id pub-id-type="pmid">17548472</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname><given-names>S</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mapping identifiers for the integration of genomic datasets with the R/bioconductor package biomart</article-title><source>Nature Protocols</source><volume>4</volume><fpage>1184</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.97</pub-id><pub-id pub-id-type="pmid">19617889</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>AG</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title><source>Behavior Research Methods</source><volume>39</volume><fpage>175</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.3758/bf03193146</pub-id><pub-id pub-id-type="pmid">17695343</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname><given-names>TE</given-names></name><name><surname>Dennison</surname><given-names>BJC</given-names></name><name><surname>Fantauzzo</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of RNA-binding proteins in vertebrate neural crest and craniofacial development</article-title><source>Journal of Developmental Biology</source><volume>9</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.3390/jdb9030034</pub-id><pub-id pub-id-type="pmid">34564083</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Insights into neural crest development from studies of avian embryos</article-title><source>The International Journal of Developmental Biology</source><volume>62</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1387/ijdb.180038sg</pub-id><pub-id pub-id-type="pmid">29616727</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Maruszko</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Thomson</surname><given-names>M</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bimodal function of chromatin remodeler <italic>hmga1</italic> in neural crest induction and wnt-dependent emigration</article-title><source>eLife</source><volume>9</volume><elocation-id>e57779</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.57779</pub-id><pub-id pub-id-type="pmid">32965216</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Mauriño</surname><given-names>SM</given-names></name><name><surname>Rivero-Rodríguez</surname><given-names>F</given-names></name><name><surname>Velázquez-Cruz</surname><given-names>A</given-names></name><name><surname>Hernández-Vellisca</surname><given-names>M</given-names></name><name><surname>Díaz-Quintana</surname><given-names>A</given-names></name><name><surname>De la Rosa</surname><given-names>MA</given-names></name><name><surname>Díaz-Moreno</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RNA binding protein regulation and cross-talk in the control of AU-rich mrna fate</article-title><source>Frontiers in Molecular Biosciences</source><volume>4</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2017.00071</pub-id><pub-id pub-id-type="pmid">29109951</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcription factors in craniofacial development: from receptor signaling to transcriptional and epigenetic regulation</article-title><source>Current Topics in Developmental Biology</source><volume>115</volume><fpage>377</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.07.009</pub-id><pub-id pub-id-type="pmid">26589933</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grammatikakis</surname><given-names>I</given-names></name><name><surname>Abdelmohsen</surname><given-names>K</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Posttranslational control of hur function</article-title><source>Wiley Interdisciplinary Reviews. RNA</source><volume>8</volume><fpage>231</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1002/wrna.1372</pub-id><pub-id pub-id-type="pmid">27307117</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname><given-names>V</given-names></name><name><surname>Hamilton</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="1951">1951</year><article-title>A series of normal stages in the development of the chick embryo</article-title><source>Journal of Morphology</source><volume>88</volume><fpage>49</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/jmor.1050880104</pub-id><pub-id pub-id-type="pmid">24539719</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovland</surname><given-names>AS</given-names></name><name><surname>Rothstein</surname><given-names>M</given-names></name><name><surname>Simoes-Costa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Network architecture and regulatory logic in neural crest development</article-title><source>Wiley Interdisciplinary Reviews. Systems Biology and Medicine</source><volume>12</volume><elocation-id>e1468</elocation-id><pub-id pub-id-type="doi">10.1002/wsbm.1468</pub-id><pub-id pub-id-type="pmid">31702881</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Szaro</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>C-jun N-terminal kinase phosphorylation of heterogeneous nuclear ribonucleoprotein K regulates vertebrate axon outgrowth via a posttranscriptional mechanism</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>14666</fpage><lpage>14680</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4821-12.2013</pub-id><pub-id pub-id-type="pmid">24027268</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Draxin acts as a molecular rheostat of canonical wnt signaling to control cranial neural crest EMT</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>3683</fpage><lpage>3697</lpage><pub-id pub-id-type="doi">10.1083/jcb.201709149</pub-id><pub-id pub-id-type="pmid">30026247</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Draxin alters laminin organization during basement membrane remodeling to control cranial neural crest EMT</article-title><source>Developmental Biology</source><volume>446</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.12.021</pub-id><pub-id pub-id-type="pmid">30579765</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>P-Bodies Are Sites of Rapid RNA Decay during the Neural Crest Epithelial—Mesenchymal Transition</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.31.231860</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptomic identification of draxin-responsive targets during cranial neural crest EMT</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>624037</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.624037</pub-id><pub-id pub-id-type="pmid">33613313</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaseelan</surname><given-names>S</given-names></name><name><surname>Doyle</surname><given-names>F</given-names></name><name><surname>Tenenbaum</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Profiling post-transcriptionally networked mrna subsets using RIP-chip and RIP-seq</article-title><source>Methods</source><volume>67</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.11.001</pub-id><pub-id pub-id-type="pmid">24257445</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalev-Altman</surname><given-names>R</given-names></name><name><surname>Hanael</surname><given-names>E</given-names></name><name><surname>Zelinger</surname><given-names>E</given-names></name><name><surname>Blum</surname><given-names>M</given-names></name><name><surname>Monsonego-Ornan</surname><given-names>E</given-names></name><name><surname>Sela-Donenfeld</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Conserved role of matrix metalloproteases 2 and 9 in promoting the migration of neural crest cells in avian and mammalian embryos</article-title><source>FASEB Journal</source><volume>34</volume><fpage>5240</fpage><lpage>5261</lpage><pub-id pub-id-type="doi">10.1096/fj.201901217RR</pub-id><pub-id pub-id-type="pmid">32067275</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsanou</surname><given-names>V</given-names></name><name><surname>Milatos</surname><given-names>S</given-names></name><name><surname>Yiakouvaki</surname><given-names>A</given-names></name><name><surname>Sgantzis</surname><given-names>N</given-names></name><name><surname>Kotsoni</surname><given-names>A</given-names></name><name><surname>Alexiou</surname><given-names>M</given-names></name><name><surname>Harokopos</surname><given-names>V</given-names></name><name><surname>Aidinis</surname><given-names>V</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name><name><surname>Kontoyiannis</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The RNA-binding protein elavl1/hur is essential for placental branching morphogenesis and embryonic development</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>2762</fpage><lpage>2776</lpage><pub-id pub-id-type="doi">10.1128/MCB.01393-08</pub-id><pub-id pub-id-type="pmid">19307312</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keene</surname><given-names>JD</given-names></name><name><surname>Tenenbaum</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Eukaryotic mrnps may represent posttranscriptional operons</article-title><source>Molecular Cell</source><volume>9</volume><fpage>1161</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(02)00559-2</pub-id><pub-id pub-id-type="pmid">12086614</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keene</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RNA regulons: coordination of post-transcriptional events</article-title><source>Nature Reviews. Genetics</source><volume>8</volume><fpage>533</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1038/nrg2111</pub-id><pub-id pub-id-type="pmid">17572691</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Jeong</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HuR represses wnt/β-catenin-mediated transcriptional activity by promoting cytoplasmic localization of β-catenin</article-title><source>Biochemical and Biophysical Research Communications</source><volume>457</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.12.052</pub-id><pub-id pub-id-type="pmid">25534855</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Ouyang</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>JN</given-names></name><name><surname>Zou</surname><given-names>T</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Chung</surname><given-names>HK</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Donahue</surname><given-names>JM</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Competition between RNA-binding proteins CELF1 and hur modulates MYC translation and intestinal epithelium renewal</article-title><source>Molecular Biology of the Cell</source><volume>26</volume><fpage>1797</fpage><lpage>1810</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-11-1500</pub-id><pub-id pub-id-type="pmid">25808495</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Campbell</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name><name><surname>Furneaux</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cloning and characterization of hur, a ubiquitously expressed elav-like protein</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>8144</fpage><lpage>8151</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.14.8144</pub-id><pub-id pub-id-type="pmid">8626503</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Manohar</surname><given-names>S</given-names></name><name><surname>Camacho</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cadherin-11 Is Required for Neural Crest Determination and Survival</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.05.18.066613</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martik</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulatory logic underlying diversification of the neural crest</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>715</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.07.015</pub-id><pub-id pub-id-type="pmid">28851604</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet.Journal</source><volume>17</volume><fpage>10</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megason</surname><given-names>SG</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A mitogen gradient of dorsal midline wnts organizes growth in the CNS</article-title><source>Development</source><volume>129</volume><fpage>2087</fpage><lpage>2098</lpage><pub-id pub-id-type="doi">10.1242/dev.129.9.2087</pub-id><pub-id pub-id-type="pmid">11959819</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milet</surname><given-names>C</given-names></name><name><surname>Monsoro-Burq</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neural crest induction at the neural plate border in vertebrates</article-title><source>Developmental Biology</source><volume>366</volume><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2012.01.013</pub-id><pub-id pub-id-type="pmid">22305800</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monier-Gavelle</surname><given-names>F</given-names></name><name><surname>Duband</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Control of N-cadherin-mediated intercellular adhesion in migrating neural crest cells in vitro</article-title><source>Journal of Cell Science</source><volume>108 (Pt 12)</volume><fpage>3839</fpage><lpage>3853</lpage><pub-id pub-id-type="doi">10.1242/jcs.108.12.3839</pub-id><pub-id pub-id-type="pmid">8719890</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsonego-Ornan</surname><given-names>E</given-names></name><name><surname>Kosonovsky</surname><given-names>J</given-names></name><name><surname>Bar</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>L</given-names></name><name><surname>Fraggi-Rankis</surname><given-names>V</given-names></name><name><surname>Simsa</surname><given-names>S</given-names></name><name><surname>Kohl</surname><given-names>A</given-names></name><name><surname>Sela-Donenfeld</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Matrix metalloproteinase 9/gelatinase B is required for neural crest cell migration</article-title><source>Developmental Biology</source><volume>364</volume><fpage>162</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2012.01.028</pub-id><pub-id pub-id-type="pmid">22342386</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>N</given-names></name><name><surname>Corcoran</surname><given-names>DL</given-names></name><name><surname>Nusbaum</surname><given-names>JD</given-names></name><name><surname>Reid</surname><given-names>DW</given-names></name><name><surname>Georgiev</surname><given-names>S</given-names></name><name><surname>Hafner</surname><given-names>M</given-names></name><name><surname>Ascano</surname><given-names>M</given-names></name><name><surname>Tuschl</surname><given-names>T</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Keene</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative regulatory mapping indicates that the RNA-binding protein hur couples pre-mrna processing and mrna stability</article-title><source>Molecular Cell</source><volume>43</volume><fpage>327</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.06.007</pub-id><pub-id pub-id-type="pmid">21723170</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabis</surname><given-names>M</given-names></name><name><surname>Popowicz</surname><given-names>GM</given-names></name><name><surname>Stehle</surname><given-names>R</given-names></name><name><surname>Fernández-Ramos</surname><given-names>D</given-names></name><name><surname>Asami</surname><given-names>S</given-names></name><name><surname>Warner</surname><given-names>L</given-names></name><name><surname>García-Mauriño</surname><given-names>SM</given-names></name><name><surname>Schlundt</surname><given-names>A</given-names></name><name><surname>Martínez-Chantar</surname><given-names>ML</given-names></name><name><surname>Díaz-Moreno</surname><given-names>I</given-names></name><name><surname>Sattler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HuR biological function involves RRM3-mediated dimerization and RNA binding by all three rrms</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>1011</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1138</pub-id><pub-id pub-id-type="pmid">30418581</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piacentino</surname><given-names>ML</given-names></name><name><surname>Hutchins</surname><given-names>EJ</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Essential function and targets of BMP signaling during midbrain neural crest delamination</article-title><source>Developmental Biology</source><volume>477</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.06.003</pub-id><pub-id pub-id-type="pmid">34102166</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabadán</surname><given-names>MA</given-names></name><name><surname>Herrera</surname><given-names>A</given-names></name><name><surname>Fanlo</surname><given-names>L</given-names></name><name><surname>Usieto</surname><given-names>S</given-names></name><name><surname>Carmona-Fontaine</surname><given-names>C</given-names></name><name><surname>Barriga</surname><given-names>EH</given-names></name><name><surname>Mayor</surname><given-names>R</given-names></name><name><surname>Pons</surname><given-names>S</given-names></name><name><surname>Martí</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Delamination of neural crest cells requires transient and reversible wnt inhibition mediated by dact1/2</article-title><source>Development</source><volume>143</volume><fpage>2194</fpage><lpage>2205</lpage><pub-id pub-id-type="doi">10.1242/dev.134981</pub-id><pub-id pub-id-type="pmid">27122165</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothamel</surname><given-names>K</given-names></name><name><surname>Arcos</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Reasoner</surname><given-names>C</given-names></name><name><surname>Lisy</surname><given-names>S</given-names></name><name><surname>Mukherjee</surname><given-names>N</given-names></name><name><surname>Ascano</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ELAVL1 primarily couples mrna stability with the 3’ utrs of interferon-stimulated genes</article-title><source>Cell Reports</source><volume>35</volume><elocation-id>109178</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109178</pub-id><pub-id pub-id-type="pmid">34038724</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez-Vásquez</surname><given-names>E</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name><name><surname>Strobl-Mazzulla</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epigenetic inactivation of mir-203 as a key step in neural crest epithelial-to-mesenchymal transition</article-title><source>Development</source><volume>146</volume><elocation-id>dev171017</elocation-id><pub-id pub-id-type="doi">10.1242/dev.171017</pub-id><pub-id pub-id-type="pmid">30910825</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scotto-Lavino</surname><given-names>E</given-names></name><name><surname>Du</surname><given-names>G</given-names></name><name><surname>Frohman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>3’ end cdna amplification using classic RACE</article-title><source>Nature Protocols</source><volume>1</volume><fpage>2742</fpage><lpage>2745</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.481</pub-id><pub-id pub-id-type="pmid">17406530</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Heng</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>BF</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>HL</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>QC</given-names></name><name><surname>Yang</surname><given-names>YG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RNA structural dynamics regulate early embryogenesis through controlling transcriptome fate and function</article-title><source>Genome Biology</source><volume>21</volume><elocation-id>120</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-020-02022-2</pub-id><pub-id pub-id-type="pmid">32423473</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simões-Costa</surname><given-names>M</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Establishing neural crest identity: a gene regulatory recipe</article-title><source>Development</source><volume>142</volume><fpage>242</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1242/dev.105445</pub-id><pub-id pub-id-type="pmid">25564621</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simões-Costa</surname><given-names>M</given-names></name><name><surname>Stone</surname><given-names>M</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Axud1 integrates wnt signaling and transcriptional inputs to drive neural crest formation</article-title><source>Developmental Cell</source><volume>34</volume><fpage>544</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.06.024</pub-id><pub-id pub-id-type="pmid">26256212</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steventon</surname><given-names>B</given-names></name><name><surname>Mayor</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Early neural crest induction requires an initial inhibition of wnt signals</article-title><source>Developmental Biology</source><volume>365</volume><fpage>196</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2012.02.029</pub-id><pub-id pub-id-type="pmid">22394485</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strobl-Mazzulla</surname><given-names>PH</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A PHD12-snail2 repressive complex epigenetically mediates neural crest epithelial-to-mesenchymal transition</article-title><source>The Journal of Cell Biology</source><volume>198</volume><fpage>999</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1083/jcb.201203098</pub-id><pub-id pub-id-type="pmid">22986495</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taneyhill</surname><given-names>LA</given-names></name><name><surname>Coles</surname><given-names>EG</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Snail2 directly represses cadherin6b during epithelial-to-mesenchymal transitions of the neural crest</article-title><source>Development</source><volume>134</volume><fpage>1481</fpage><lpage>1490</lpage><pub-id pub-id-type="doi">10.1242/dev.02834</pub-id><pub-id pub-id-type="pmid">17344227</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribulo</surname><given-names>C</given-names></name><name><surname>Aybar</surname><given-names>MJ</given-names></name><name><surname>Nguyen</surname><given-names>VH</given-names></name><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Mayor</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of msx genes by a bmp gradient is essential for neural crest specification</article-title><source>Development</source><volume>130</volume><fpage>6441</fpage><lpage>6452</lpage><pub-id pub-id-type="doi">10.1242/dev.00878</pub-id><pub-id pub-id-type="pmid">14627721</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tutucci</surname><given-names>E</given-names></name><name><surname>Vera</surname><given-names>M</given-names></name><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Garcia</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name><name><surname>Singer</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An improved MS2 system for accurate reporting of the mrna life cycle</article-title><source>Nature Methods</source><volume>15</volume><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4502</pub-id><pub-id pub-id-type="pmid">29131164</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Limborgh</surname><given-names>J</given-names></name><name><surname>Lieuw Kie Song</surname><given-names>SH</given-names></name><name><surname>Been</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Cleft lip and palate due to deficiency of mesencephalic neural crest cells</article-title><source>The Cleft Palate Journal</source><volume>20</volume><fpage>251</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">6577988</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vega-Lopez</surname><given-names>GA</given-names></name><name><surname>Cerrizuela</surname><given-names>S</given-names></name><name><surname>Tribulo</surname><given-names>C</given-names></name><name><surname>Aybar</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neurocristopathies: new insights 150 years after the neural crest discovery</article-title><source>Developmental Biology</source><volume>444 Suppl 1</volume><fpage>S110</fpage><lpage>S143</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.05.013</pub-id><pub-id pub-id-type="pmid">29802835</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>NJ</given-names></name><name><surname>Green</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Dalmay</surname><given-names>T</given-names></name><name><surname>Münsterberg</surname><given-names>A</given-names></name><name><surname>Moxon</surname><given-names>S</given-names></name><name><surname>Wheeler</surname><given-names>GN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MicroRNAs associated with early neural crest development in <italic>Xenopus laevis</italic></article-title><source>BMC Genomics</source><volume>19</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-018-4436-0</pub-id><pub-id pub-id-type="pmid">29347911</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>AMJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MicroRNAs and the neural crest: from induction to differentiation</article-title><source>Mechanisms of Development</source><volume>154</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2018.05.009</pub-id><pub-id pub-id-type="pmid">29859253</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RM</given-names></name><name><surname>Candido-Ferreira</surname><given-names>I</given-names></name><name><surname>Repapi</surname><given-names>E</given-names></name><name><surname>Gavriouchkina</surname><given-names>D</given-names></name><name><surname>Senanayake</surname><given-names>U</given-names></name><name><surname>Ling</surname><given-names>ITC</given-names></name><name><surname>Telenius</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Sauka-Spengler</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reconstruction of the global neural crest gene regulatory network in vivo</article-title><source>Developmental Cell</source><volume>51</volume><fpage>255</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.003</pub-id><pub-id pub-id-type="pmid">31639368</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name><name><surname>Klein</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Wnt-frizzled signaling in neural crest formation</article-title><source>Trends in Neurosciences</source><volume>26</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/s0166-2236(02)00011-5</pub-id><pub-id pub-id-type="pmid">12495862</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanfeng</surname><given-names>W</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name><name><surname>Klein</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Wnt-frizzled signaling in the induction and differentiation of the neural crest</article-title><source>BioEssays</source><volume>25</volume><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/bies.10255</pub-id><pub-id pub-id-type="pmid">12655639</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>KM</given-names></name><name><surname>Samson</surname><given-names>ML</given-names></name><name><surname>Reeves</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Gene elav of <italic>Drosophila melanogaster</italic>: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans</article-title><source>Journal of Neurobiology</source><volume>24</volume><fpage>723</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1002/neu.480240604</pub-id><pub-id pub-id-type="pmid">8331337</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Sanders</surname><given-names>AJ</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9</article-title><source>Oncology Reports</source><volume>26</volume><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.3892/or.2011.1271</pub-id><pub-id pub-id-type="pmid">21503589</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuker</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title><source>Nucleic Acids Research</source><volume>31</volume><fpage>3406</fpage><lpage>3415</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg595</pub-id><pub-id pub-id-type="pmid">12824337</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Elavl1</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NM_204833.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Draxin</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">AB427147.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Axud1 (CSRNP1)</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">GenBank: ON920861</td><td align="left" valign="bottom">3′-Untranslated region</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Msx1</italic></td><td align="left" valign="bottom">Ensembl</td><td align="left" valign="bottom">ENSGALT00000024209.4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>BMP4</italic></td><td align="left" valign="bottom">Ensembl</td><td align="left" valign="bottom">ENSGALT00000020316.7</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Tfap2b</italic></td><td align="left" valign="bottom">Ensembl</td><td align="left" valign="bottom">ENSGALT00000026916.6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom"><italic>Pax7</italic></td><td align="left" valign="bottom">Ensembl</td><td align="left" valign="bottom">ENSGALT00000048594.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Gallus gallus</italic>)</td><td align="left" valign="bottom">Rhode Island Red</td><td align="left" valign="bottom">Sun State Ranch (Monrovia, CA, USA)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit anti-Elavl1</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab196626</td><td align="left" valign="bottom">1:100 immunohistochemistry; <break/>5 µg immunoprecipitation</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse IgG1 anti-Pax7</td><td align="left" valign="bottom">Developmental Studies Hybridoma Bank</td><td align="left" valign="bottom">Cat# pax7, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528428">AB_528428</ext-link></td><td align="char" char="." valign="bottom">1:5</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat IgG anti-GFP</td><td align="left" valign="bottom">Rockland</td><td align="left" valign="bottom">Cat# 600-101-215, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_218182">AB_218182</ext-link></td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit IgG, polyclonal – Isotype Control (ChIP Grade)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab171870</td><td align="left" valign="bottom">5 µg immunoprecipitation</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCI-H2B-RFP (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Betancur et al., 2010</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCIG (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Megason and McMahon, 2002</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Draxin-FLAG (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">MCP-GFP (plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Hutchins et al., 2020</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">MS2-Draxin 3′-UTR (plasmid)</td><td align="left" valign="bottom">This paper; <xref ref-type="bibr" rid="bib30">Hutchins et al., 2020</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Control morpholino</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">CCTCTTACCTCAGTTACAATTTATA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Elavl1 morpholino</td><td align="left" valign="bottom">This paper; GeneTools</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">GACATCTTATAACGTATCTCGCTGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Draxin morpholino</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Hutchins and Bronner, 2018</xref>; GeneTools</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">AAGGTGGAAGAAGCTGCCATAATCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Draxin qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">CTACGCTGTTATGCCAAATTCC</named-content>; <break/>Reverse: 5′-<named-content content-type="sequence">GAATGATCCCTGCTCTCCATT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Axud1 qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">TCCAGTCCTTCTCGGACTATAA</named-content>; <break/>Reverse: 5′-<named-content content-type="sequence">GGGAAATTAGGCAACTGAAACTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Msx1 qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">AGCTGGAGAAGCTGAAGATG</named-content>; Reverse: 5′-<named-content content-type="sequence">AGGCTCCGTACAGGGAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BMP4 qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">TTGGTCAACTCCGTCAACTC</named-content>; <break/>Reverse: 5′-<named-content content-type="sequence">CAGCACCACCTTGTCATACT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Pax7 qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">CAAACCAACTCGCAGCATTC</named-content>; <break/>Reverse: 5′-<named-content content-type="sequence">CTGCCTCCATCTTGGGAAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FoxD3 qPCR primers</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">Forward: 5′-<named-content content-type="sequence">CATCTGCGAGTTCATCAGCA; Reverse: 5'-TTCACGAAGCAGTCGTTGAG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">3′-RACE QT primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Scotto-Lavino et al., 2006</xref>; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">CCAGTGAGCAGAGTGACGAGGACTCGAGCTCAAGCTTTTTTTTTTTTTTTTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">3′-RACE QO primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Scotto-Lavino et al., 2006</xref>; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">CCAGTGAGCAGAGTGACG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">3′-RACE QI primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Scotto-Lavino et al., 2006</xref>; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">GAGGACTCGAGCTCAAGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">3′-RACE Axud1 Gene Specific Primer 1</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">CGTGTTCCAAGAGCTATGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">3′-RACE Axud1 Gene Specific Primer 2</td><td align="left" valign="bottom">This paper; IDT</td><td align="left" valign="bottom">Custom DNA oligos</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">GGTTTCCCGCAAGCTGG</named-content></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAqueous-Micro Total RNA isolation kit</td><td align="left" valign="bottom">Ambion</td><td align="left" valign="bottom">Cat# AM1931</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SMART-Seq v4 Ultra Low Input cDNA kit</td><td align="left" valign="bottom">Takara Bio</td><td align="left" valign="bottom">Cat# 634889</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Agencourt AMPure XP beads</td><td align="left" valign="bottom">Beckman Coulter</td><td align="left" valign="bottom">Cat# A63880</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Endofree maxi prep kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Cat# 12362</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Duolink In Situ PLA Probe Anti-Rabbit MINUS</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# DUO92005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Duolink In Situ PLA Probe Anti-Goat PLUS</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# DUO92003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Duolink In Situ Detection Reagents FarRed</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# DUO92013</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Duolink In Situ Wash Buffers, Fluorescence</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# DUO82049</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Duolink In Situ Mounting Medium with DAPI</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# DUO82040</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluoromount-G</td><td align="left" valign="bottom">SouthernBiotech</td><td align="left" valign="bottom">Cat# 0100-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# D1306</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FastStart Universal SYBR Green Master (Rox)</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# FSUSGMMRO</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SuperScript III Reverse Transcriptase</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 18080044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">cOmplete, Mini, EDTA-free Protease Inhibitor</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# 11836170001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNaseOUT Recombinant Ribonuclease Inhibitor</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 10777019</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Accumax</td><td align="left" valign="bottom">Innovative Cell Technologies, Inc</td><td align="left" valign="bottom">Cat# AM105</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Protein G Dynabeads</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 10003D</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Actinomycin D</td><td align="left" valign="bottom">Millipore/Sigma</td><td align="left" valign="bottom">Cat# A9415</td><td align="left" valign="bottom">10 µg/ml</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib54">Schindelin et al., 2012</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Butler et al., 2018</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007322">SCR_007322</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/">https://satijalab.org/seurat/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">QuantStudio Design &amp; Analysis software, version 2.4</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018712">SCR_018712</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Zen 2 Blue</td><td align="left" valign="bottom">Zeiss</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Zen Black</td><td align="left" valign="bottom">Zeiss</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Photoshop CC</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism8, Prism9</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FastQC</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Andrews, 2014</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014583">SCR_014583</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cutadapt</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Martin, 2011</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011841">SCR_011841</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bowtie2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Langmead and Salzberg, 2012</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016368">SCR_016368</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HTSeq-Count</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011867">SCR_011867</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">biomaRt package</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Durinck et al., 2009</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019214">SCR_019214</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">mfold</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib73">Zuker, 2003</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008543">SCR_008543</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">G*Power</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Faul et al., 2007</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013726">SCR_013726</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other, deposited data</td><td align="left" valign="bottom">sc-RNA (SmartSeq2)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib68">Williams et al., 2019</xref></td><td align="left" valign="bottom">GEO: GSE130500</td><td align="left" valign="bottom">Single-cell RNA-sequencing datasets; see <xref ref-type="fig" rid="fig1">Figure 1</xref> and Data Availability Statement</td></tr><tr><td align="left" valign="bottom">Other, deposited data</td><td align="left" valign="bottom">RNA-seq data (bulk)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">NCBI Bioproject: PRJNA861325</td><td align="left" valign="bottom">Single-end RNA-sequencing datasets; see <xref ref-type="fig" rid="fig4">Figure 4</xref> and Data Availability Statement</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63600.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Robertson</surname><given-names>Elizabeth</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>In this short report, Hutchins et al. reveal expression of the RNA-binding protein (RBP) HuR in the neural tube and cranial neural crest of chicken embryos. Knock-down of HuR affects expression of Axud1 and FoxD3 (both genes associated with neural crest specification) and of the Wnt antagonist Draxin previously shown by the authors to regulate neural crest specification and delamination. The authors propose that HuR associates with Draxin mRNA and demonstrate that Draxin overexpression can rescue FoxD3 expression upon HuR knock down. The data is in line with the idea that control of neural crest specification by HuR at least partially involves Draxin mRNA stabilization.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63600.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Robertson</surname><given-names>Elizabeth</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Sommer</surname><given-names>Lukas</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kathryn Cheah as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Lukas Sommer (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In this short report, Hutchins et al., reveal expression of the RNA-binding protein (RBP) HuR in the neural tube and cranial neural crest of chicken embryos. Knock-down of HuR affects expression of Axud1 and FoxD3 (both genes associated with neural crest specification) and of the Wnt antagonist Draxin previously shown by the authors to regulate neural crest specification and delamination. The authors propose that HuR associates with Draxin mRNA and demonstrate that Draxin overexpression can rescue FoxD3 expression upon HuR knock down. The data is in line with the idea that control of neural crest specification by HuR at least partially involves Draxin mRNA stabilization.</p><p>Essential revisions:</p><p>As outlined below in the largely unedited Reviewers comments, they suggest a major re-write of the paper.</p><p>Overall, Reviewer 1 commented that unraveling the gene regulatory network (GRN) of neural crest specification has been the focus of many recent studies. How the GRN is modulated by post-transcriptional control mechanisms, as addressed here, is an important and relevant question. However they feel that the authors missed an opportunity to address this question in a broader manner. Moreover, the evidence that HuR regulates Draxin post-transcriptionally (by mRNA stabilization) has to be strengthened.</p><p>Overall, Reviewer 2 commented that the main problem about this work is that the central player of the story seems to be a ubiquitous expressed molecule (a paper in the literature mentions Elavl1 as &quot;universally&quot; expressed). In the early chicken embryo, the situation does not seem very different, since it is certainly expressed in forming NC/NT, but also in other tissues (ectoderm, mesoderm, Figure 1). Thus reader might conclude that it is not very surprising that when mRNAs are less stable, most tissues, including NC, do not perform as expected. Indeed they have shown that the three genes they have tested (Axud1, FoxD3 and Draxin) are all down-regulated after Elavl1 knock-down.</p><p>Major Points:</p><p>1) According to the Abstract and in the Introduction, the authors' goal of this study was the identification of potential post-transcriptional regulators of neural crest specification. Specifically, they &quot;sought to identify RBPs with early roles in neural crest development&quot;. This is an intriguing research question. However, rather than systematically assessing RBPs in their RNA seq datasets, they picked Elav1/HuR for their further experiments. Why? Likely, this was not the only RBP in their RNA seq datasets. Was Elav1 (encoding HuR) the most enriched RBP? These data should be shown and the reason for picking Elav1/HuR should be clarified.</p><p>2) In Figure 1D', expression of HuR in migratory neural crest is not evident. Transverse section at HH9+ might help revealing HuR expression in migratory neural crest cells.</p><p>3) The link between HuR and Draxin is rather weak and seems again a bit 'cherry picked'. I recommend a more global assay to identify mRNA targets of HuR (e.g. CLIP seq). As correctly stated in the Discussion, HuR is also known to stabilize Snail1 and other mRNAs with roles in neural crest development, which could all mediate post-transcriptional regulation of neural crest specification and, therefore, mediate the observed phenotypes. Importantly, in Figure 3, enrichment of Draxin mRNA is not very convincing, in particular when compared to its control (non-specific control IP) rather than to Pax7/FoxD3 values (which for reasons unclear to me are highly negative). A positive control should be included (e.g. a previously identified mRNA target of HuR). Can Draxin mRNA binding by HuR be confirmed by other means (such as CLIP seq)? It should be addressed whether Draxin mRNA stability is indeed affected by HuR knock down.</p><p>4) The Draxin overexpression rescue experiment is nice, but should be extended to other parameters of neural crest specification (the authors only checked FoxD3 expression). What about other markers? What about delamination?</p><p>5) The authors show that the three genes they have tested (Axud1, FoxD3 and Draxin) are all down-regulated after Elavl1 knock-down. The experiment shown in Figure 4 somewhat dampens this impression by suggesting that not all those mRNAs bind to Elavl1, but it would give weight to these findings if the authors would i) support this data by checking in silico on the many RNAseq data they have gathered over the years that only a subpopulation of &quot;NC genes&quot; display Elavl1 target sequences in their UTR and ii) verify that some of those genes are unaffected after Elavl1 MO electroporation (using the same approach than in Figure 2). This would support the idea that even though Elavl1 may be ubiquitously expressed, its targets are restricted and that we are looking at a regulated biological process and not so much at a house-keeping activity.</p><p>If these authors can show some specificity in Elavl1 function, this could also be an opportunity to re-write part of the text and convey a more general idea/concept on the importance of RNA stability in biology, something that we use on a daily basis when designing expression vectors, but which has obviously real-life implications.</p><p>6) It would also help if the authors use Elavl1 gain-of-function approaches to support the data presented here (would it over-stabilize Draxin, for instance?).</p><p>7) Very little (in fact nothing) is said in the introduction about existing work on full and conditional KO of Elavl1 in mouse (Katsanou et al., 2009), which sends the message that the present work stands on its own. Katsanou's paper is in fact quite extensive and it describes a number of phenotypes that the authors observed in different genetic settings. This has to be included in the present paper (i.e. it should be introduced/discussed upfront), with the aim of convincing the reader that there is still something to be understood about the function of Elavl1 and that the (advantages of the model) chicken embryo can address those questions in a more precise way than the murine model does.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63600.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) According to the Abstract and in the Introduction, the authors' goal of this study was the identification of potential post-transcriptional regulators of neural crest specification. Specifically, they &quot;sought to identify RBPs with early roles in neural crest development&quot;. This is an intriguing research question. However, rather than systematically assessing RBPs in their RNA seq datasets, they picked Elav1/HuR for their further experiments. Why? Likely, this was not the only RBP in their RNA seq datasets. Was Elav1 (encoding HuR) the most enriched RBP? These data should be shown and the reason for picking Elav1/HuR should be clarified.</p></disp-quote><p>We acknowledge the reviewers’ point, which made us realize that we did not adequately explain why we chose to focus on Elav1/HuR as a post-transcriptional regulator of neural crest development. We now clarify that this is one of the few such genes that we have found enriched in the premigratory neural crest. To better demonstrate this, we have re-analyzed a recently published scRNA-seq dataset (Williams et al., 2019). We have reorganized the paper and now include this analysis as a new Figure 1 to further clarify our choice for selecting Elavl1 for follow up.</p><p>In the revised manuscript, we highlight that several RNA-binding proteins are expressed to varying degrees in cranial neural crest cells. Using gene ontology analysis, we generated a three-way Venn diagram to identify overlap between genes associated with the gene ontology terms “binds RNA,” “regulates translation,” and “stabilizes RNA.” Only three genes, Elavl1, Dazl, and Igf2bp1, were associated with all three, and only Elavl1 is abundant amongst all sorted cranial neural crest cells.</p><p>We have now included this expanded justification in the text.</p><disp-quote content-type="editor-comment"><p>2) In Figure 1D', expression of HuR in migratory neural crest is not evident. Transverse section at HH9+ might help revealing HuR expression in migratory neural crest cells.</p></disp-quote><p>We have added a transverse section at HH9+ showing Elavl1 expression in migratory neural crest cells. This is now included in Figure 2F-G.</p><disp-quote content-type="editor-comment"><p>3) The link between HuR and Draxin is rather weak and seems again a bit 'cherry picked'. I recommend a more global assay to identify mRNA targets of HuR (e.g. CLIP seq).</p></disp-quote><p>We thank the reviewers for raising this good point. To more broadly identify targets of</p><p>Elavl1, we performed differential RNA-sequencing analysis on dissected neural folds (representing premigratory neural crest) for control vs Elavl1 knockdown (Figure 4). We identified 24 differentially expressed genes (12 downregulated, 12 upregulated). Among those genes, only four were known to have roles in neural crest development and were found to be significantly downregulated with Elavl1 knockdown—<italic>Draxin</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, and <italic>BMP4</italic>. The downregulation of these transcripts with Elavl1 knockdown was confirmed in vivo using HCR (Figure 3, Figure 4-Supplement 1).</p><disp-quote content-type="editor-comment"><p>As correctly stated in the Discussion, HuR is also known to stabilize Snail1 and other mRNAs with roles in neural crest development, which could all mediate post-transcriptional regulation of neural crest specification and, therefore, mediate the observed phenotypes.</p></disp-quote><p>The reviewers raise an important point. However, Snail1 is not expressed in chick cranial neural crest at these stages (del Barrio and Nieto, 2002, Development, 129(7):1583-93); rather Snail2 is the predominant Snail family transcription factor at this time and place in chick embryos. Importantly, our newly added RNA-seq data and HCR for Snai2 (Figure 4-Supplement 1) indicate that, indeed, Snai2 expression is unaffected by Elavl1 knockdown, and is unlikely to be a direct target of Elavl1 at the premigratory stage.</p><disp-quote content-type="editor-comment"><p>Importantly, in Figure 3, enrichment of Draxin mRNA is not very convincing, in particular when compared to its control (non-specific control IP) rather than to Pax7/FoxD3 values (which for reasons unclear to me are highly negative). A positive control should be included (e.g. a previously identified mRNA target of HuR). Can Draxin mRNA binding by HuR be confirmed by other means (such as CLIP seq)?</p></disp-quote><p>Thank you for this comment, which made us realize that this experiment needed to be better documented. Accordingly, we have modified the presentation of this RIP data to display Fold Enrichment, in keeping with other studies that have performed RIP experiments for Elavl1 (Rothamel et al., 2021). We hope this better illustrates the enrichment of <italic>Draxin</italic> mRNA over non-targets <italic>FoxD3</italic> and <italic>Pax7</italic>.</p><p>While it would be ideal to use an experiment such as CLIP-seq to confirm direct binding, CLIP-seq (and similar cross-linking experiments) require large amounts of starting material that make this approach unfeasible for embryonic tissue. However, in an effort to provide demonstration of <italic>Draxin</italic> mRNA binding by Elavl1 through other means, we have now included a proximity ligation assay experiment (Figure 4G) as a secondary means to demonstrate a direct interaction. Proximity ligation is a well-established technique used to demonstrate direct protein-protein interactions. We have now adapted this method to interrogate a protein-RNA interaction. For this experiment, we created an expression construct containing the Luciferase coding sequence followed by MS2 stem loops and the <italic>Draxin</italic>-3’UTR. When transcribed, and co-expressed with an MCP-GFP construct, the MS2 stem loops in the mRNA transcript are bound by MCP-GFP. Thus, if Elavl1 binds to the <italic>Draxin</italic>-3’UTR, a proximity ligation assay using antibodies to Elavl1 and GFP will generate fluorescent puncta. Using this approach, we now demonstrate that endogenous Elavl1 physically interacts with the 3’UTR of <italic>Draxin</italic> (Figure 4H-I).</p><disp-quote content-type="editor-comment"><p>It should be addressed whether Draxin mRNA stability is indeed affected by HuR knock down.</p></disp-quote><p>Good point. To quantify changes in mRNA stability with Elavl1 knockdown, we utilized the transcriptional inhibitor actinomycin D followed by qRT-PCR to measure RNA decay for <italic>Draxin</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, and <italic>BMP4</italic>, since we found using RNA-sequencing that these four genes are all downregulated with Elavl1 knockdown. We also examined RNA decay for <italic>Pax7</italic> as a “non-target”. Interestingly, we found that only <italic>Draxin</italic> mRNA stability was significantly decreased with Elavl1 knockdown (Figure 4C-D).</p><disp-quote content-type="editor-comment"><p>4) The Draxin overexpression rescue experiment is nice, but should be extended to other parameters of neural crest specification (the authors only checked FoxD3 expression). What about other markers? What about delamination?</p></disp-quote><p>We extended the rescue experiment to also examine delamination (as we had for Figure 3 with Elavl1 knockdown). We found that Draxin overexpression was sufficient to rescue defects in delamination (Figure 5K-L). Further, we also performed HCR for <italic>Axud1</italic>, <italic>Msx1</italic>, and <italic>BMP4</italic> (in addition to <italic>FoxD3</italic>), since we found these transcripts to also be downregulated with Elavl1 knockdown. All of these transcripts were rescued from Elavl1 knockdown with Draxin overexpression (Figure 5F-J). Importantly, Draxin knockdown alone also significantly reduced expression of these same four transcripts (Figure 5A-E). Together these data support the hypothesis that <italic>Draxin</italic> is the major target of Elavl1 in cranial neural crest specification. These data are included in Figure 5.</p><disp-quote content-type="editor-comment"><p>5) The authors show that the three genes they have tested (Axud1, FoxD3 and Draxin) are all down-regulated after Elavl1 knock-down. The experiment shown in Figure 4 somewhat dampens this impression by suggesting that not all those mRNAs bind to Elavl1, but it would give weight to these findings if the authors would i) support this data by checking in silico on the many RNAseq data they have gathered over the years that only a subpopulation of &quot;NC genes&quot; display Elavl1 target sequences in their UTR and ii) verify that some of those genes are unaffected after Elavl1 MO electroporation (using the same approach than in Figure 2). This would support the idea that even though Elavl1 may be ubiquitously expressed, its targets are restricted and that we are looking at a regulated biological process and not so much at a house-keeping activity.</p><p>If these authors can show some specificity in Elavl1 function, this could also be an opportunity to re-write part of the text and convey a more general idea/concept on the importance of RNA stability in biology, something that we use on a daily basis when designing expression vectors, but which has obviously real-life implications.</p></disp-quote><p>The reviewers raise excellent points. We now include Elavl1 binding analysis for the 3’UTRs of <italic>Draxin</italic>, <italic>Axud1</italic>, <italic>Msx1</italic>, <italic>BMP4</italic>, <italic>Pax7</italic>, and <italic>Tfap2b</italic> (Figure 4-Supplement 2). Neither <italic>Axud1</italic>, <italic>Pax7</italic> nor <italic>Tfap2b</italic> contain Elavl1 binding sites, and <italic>Msx1</italic> and <italic>BMP4</italic> contain only one. Notably, the <italic>Draxin</italic>-3’UTR contains four high-probability binding sites, all in proximity on the same side of the folded structure.</p><p>Given that Elavl1 contains three RNA-recognition motifs which are known to cooperatively bind a target RNA (Pabis et al., 2018), it is possible that, in order for Elavl1 to bind and stabilize an mRNA target, it needs to establish multiple points of contact on the RNA, which may account for the specificity of function we have observed here in neural crest.</p><p>In addition to the new data figure, we also expand on the above points in the relevant section of the Results.</p><disp-quote content-type="editor-comment"><p>6) It would also help if the authors use Elavl1 gain-of-function approaches to support the data presented here (would it over-stabilize Draxin, for instance?).</p></disp-quote><p>We overexpressed Elavl1 in premigratory cranial neural crest cells (driven by the FoxD3 enhancer NC1) and performed HCR for <italic>Draxin</italic>; however, we did not observe differences in <italic>Draxin</italic> levels between the control and Elavl1 overexpressing sides at HH9. We chose not to include these data in the manuscript as we do not think it adds anything to or changes the interpretation of our data or conclusions. This finding is consistent with previous observations in HeLa cells, where reduction but not overexpression of Elavl1 altered type I IFN response (Herdy et al., 2015, Eur J Immunol 45(5):1500-11. doi: 10.1002/eji.201444979).</p><disp-quote content-type="editor-comment"><p>7) Very little (in fact nothing) is said in the introduction about existing work on full and conditional KO of Elavl1 in mouse (Katsanou et al., 2009), which sends the message that the present work stands on its own. Katsanou's paper is in fact quite extensive and it describes a number of phenotypes that the authors observed in different genetic settings. This has to be included in the present paper (i.e. it should be introduced/discussed upfront), with the aim of convincing the reader that there is still something to be understood about the function of Elavl1 and that the (advantages of the model) chicken embryo can address those questions in a more precise way than the murine model does.</p></disp-quote><p>Apologies that we did not sufficiently reference this paper. While our original draft referenced this paper in the Introduction and Results sections with respect to their findings in craniofacial development, which we felt was most pertinent, in the revised manuscript we have now expanded reference to this study in the Introduction. In light of our newly added results, we have also now added reference to this citation in the Discussion, where we describe our findings, how they relate to and build upon the Katsanou paper, and how the chick model enables us to ask these questions in a spatiotemporally controlled manner.</p></body></sub-article></article>